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Abstract  
The research project of my PhD concerns essentially the Nuclear 
Magnetic Resonance (NMR) structural studies of protein-ligand 
complexes. Studying protein interactions at the molecular level is crucial 
to the understanding of many biological processes, such as human 
diseases and drug design. NMR spectroscopy is particularly well suited 
to the investigation, at the atomic level, of the interactions between 
proteins and other molecules in solution. NMR can be used to evaluate 
the structural, thermodynamic and kinetic aspects of a binding reaction, 
even for weak protein-ligand interactions.  
In this contest, during my PhD I addressed the structural 
investigation and the study of the molecular determinants of binding of 
different bile acid binding proteins (BABPs) and their native ligands or 
synthetic drugs.  
 BABPs are small cytosolic proteins that display their function in 
the hepatocytes and enterocytes where they act as bile acids transporters 
participating to the enterohepatic circulation.   
The first part of this thesis is related to the structural determination 
of chicken liver-BABP (cL-BABP) in complex with a bile acid-based 
gadolinium(III)-chelate, a potential hepatospecific contrast agent  for 
magnetic resonance imaging (MRI). The rationale of this study derived 
from a search for new hepatospecific MRI contrast agents for the 
discrimination and diagnosis of focal lesions or hepatic malignancies.  
The second part of this thesis is focused on the characterization of 
the interactions of chicken ileal BABP (cI-BABP) with bile acids. This 
study has been performed using different approaches, such as NMR 
spectroscopy and  calorimetric measurements.  
The third part of the my thesis work is based on the NMR 
structural determination of the ternary complex between cI-BABP and 
two molecules of glycochenodeoxycholic acid (GCDA). Finally, a single 
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and double mutant of cI-BABP (A101S and H99Q/A101S) were 
produced to investigate the molecular determinants of binding 
cooperativity. 
The obtained data allow shedding light on the chemical basis of 
intracellular bile acid transport. This notion may open new avenues for 
exploration of strategies for prevention and treatment of metabolic 
diseases. 
Riassunto 
7 
Riassunto 
Il progetto svolto durante il mio Dottorato di Ricerca riguarda 
essenzialmente la cartterizzazione strutturale di complessi proteina-
legante tramite spettroscopia di Risonanza Magnetica Nucleare (NMR). 
Studiare le interazioni proteiche a livello molecolare è di fondamentale 
importanza per acquisire informazioni su molti processi biologici, quali lo 
sviluppo di malattie nell’uomo o il relativo disegno di farmaci. La 
Risonanza Magnetica Nucleare è una tecnica particolarmente adatta per la 
caratterizzazione, a livello atomico, delle interazioni tra proteine e altre 
molecole in soluzione. La Risonanza Magnetica Nucleare può essere 
utilizzata per valutare gli aspetti strutturali, termodinamici e cinetici di 
una reazione di interazione proteina-legante e può rilevare anche le 
interazioni più deboli.  
In questo contesto, durante il mio Dottorato di Ricerca ho 
affrontato l'indagine strutturale e lo studio dei determinanti molecolari 
dell’interazione di differenti proteine, le bile acid binding proteins 
(BABPs) in complesso sia con i loro leganti fisiologici sia legate a 
farmaci sintetitici. Le BABPs sono piccole proteine citosoliche che 
svolgono la loro funzione negli epatociti ed enterociti, dove agiscono 
come trasportatori intracellulari degli acidi biliari, permettendo il loro 
ricircolo tramite la circolazione enteroepatica.  
Nella prima prima parte di questa tesi viene descritta la 
determinazione strutturale tramite NMR della BABP di fegato di pollo 
(cL-BABP) in complesso con l’addotto acido biliare-Gd-DTPA, un 
potenziale agente di contrasto epatospecifo per la Risonanza Magnetica 
per Immagine (MRI). Il razionale di questo studio deriva da una ricerca di 
nuovi agenti di contrasto epatospecifici per la discriminazione e la 
diagnosi di lesioni focali o tumori nel fegato, tramite la Risonanza 
Magnetica per Immagine.  
La seconda parte di questa tesi è focalizzata sulla caratterizzazione 
delle interazioni della BABP ileale di pollo (cI-BABP) con acidi biliari. 
Riassunto 
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Questo studio è stato svolto utilizzando diversi approcci, così come la 
spettroscopia NMR e misure calorimetriche.  
La terza parte del mio lavoro di tesi si basa sulla determinazione 
strutturale tramite NMR del complesso ternario tra la CI-BABP e due 
molecole di acido glicochenodeossicolico (GCDA). Infine, un singolo e 
doppio mutante della proteina CI-BABP (A101S e H99Q/A101S) sono 
stati prodotti per studiare i determinanti molecolari della cooperatività di 
legame. 
I dati ottenuti permettono di capire le basi chimiche del trasporto 
intracellulare degli acidi biliari. Questa conoscenza può aprire nuove vie
per l'esplorazione di strategie di prevenzione e trattamento delle malattie 
metaboliche.  
Chapter 1: Introduction 
Chapter 1 
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1.1 Bile acids 
Bile acids (BAs) are amphipathic steroidal compounds derived from the 
enzymatic catabolism of cholesterol in the liver and are the most 
important constituents of bile. The predominant bile acids in humans are 
chenodeoxycholic acid (CDCA) and cholic acid (CA). These primary 
BAs are synthesized within hepatocytes and conjugated at the terminal 
(C24) carboxyl group with the amino acids taurine and glycine. This 
amidation reaction has the effect of increasing bile acid solubility and 
renders them more readily excretable into bile. Bile is an important fluid 
secreted by the liver into the intestine and serves two main functions; 
digestion and absorption of lipid-soluble nutrients and elimination of 
endogenous and exogenous substances such as bilirubin, phospholipids, 
cholesterol, drugs and toxins (1). Bile is released into the small intestine 
upon food consumption. In the ileum, after facilitating and lipid-soluble 
vitamins absorption, most of the primary bile acids are absorbed from 
intestinal lumen and transported back to the liver, for reuse. This BAs 
recycling is called enterohepatic circulation (2). The existence of the 
recycling system ensures the presence of adequate concentrations of BAs 
(pool size) in the intestinal lumen for digestion: each molecule is utilized 
many times. About 5% of the pool size of BAs is lost into the large 
intestine and finally into the feces. The fecal loss of BAs, which is 
compensated by de novo BA biosynthesis in the liver, is involved in the 
biliary secretion, as it permits the elimination of substrates that cannot be 
eliminated via renal excretion (3).  
1.1.1  Bile acid biosynthesis and modification 
The fraction of BAs that has to be synthesized to preserve the adequate 
pool size in the intestine comes mainly from catabolism of cholesterol. 
Cholesterol degradation to primary BAs can be initiated by either a 
microsomal cholesterol 7alpha-hydroxylase (the classic or neutral 
pathway) or by mitochondrial sterol 27-hydroxylase (the alternative or 
acidic pathway). In the classic pathway, the principal steps leading to 
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formation of primary BAs include the saturation of the double bond, 
epimerization of the 3;-hydroxyl group, and hydroxylation at the 7< and 
12<-positions on the sterol nucleus. 
Figure 1.1 Bile acids biosynthetic pathways. Only major regulatory steps and enzymes 
are shown (4). 
These modifications precede the oxidation and cleavage of the side-chain. 
On the contrary, in the alternative pathway, side-chain oxidation precedes 
steroid ring modification. The immediate products of the BA synthetic 
pathways are CA and CDCA, referred to as primary bile acids. While the 
classic pathway of bile acids biosynthesis is limited to hepatocytes, the 
alternative pathway exists in all tissues. In figure 1.1 is reported a 
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schematic version of these complex metabolic pathways. 
After their biosynthesis from cholesterol, BAs are conjugated with either 
glycine or taurine to increase the solubility for secretion into the bile. 
Furthermore, conjugation with glycine or taurine lowers their pKa and 
therefore renders conjugated BAs fully ionized at physiological pH. The 
result is that conjugated BAs are membrane impermeable and high BA 
concentrations can persist in bile and intestine. 
During the enterohepatic circulation, the structure of primary BAs is 
altered by the intestinal microflora into a variety of metabolites (5). 
Bacterial biotransformation regards both the side chain and the nucleus of 
BAs. The known BAs biotransformations include: deconjugation on the 
side chain and elimination of hydroxyl group at C-7 on the nucleus. Thus 
conjugated CA is converted to deoxycholic acid (DCA) and similarly the 
transformation of conjugated CDCA results in the formation of lithocholic 
acid (LCA). Because DCA and LCA are formed from primary BAs, they 
are also called “secondary bile acids”. In figure 1.2 a schematic 
representation of the BA molecule and its most common substituents at 
different position is reported. 
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Figure 1.2 Schematic representation of the bile acid molecule. The most common 
substituents for positions C-3, C-7, C-12 and C-24 are reported. 
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In the hepatocyte, secondary BAs undergo different fates. DCA is 
conjugated with glycine or taurine and secreted into bile with the primary 
BAs. Because LCA is poorly water soluble and rather toxic to cells, it is 
conjugated with glycine or taurine and sulfated at the C-3 position.  
These “double conjugates” (sulfolithocholylglycine and 
sulfolithocholyltaurine) are excreted into bile but, in contrast to the 
conjugates of primary BAs and of DCA, they are not efficiently absorbed 
from the small intestine. As a result, they are quickly eliminated from the 
organism by biliary excretion (6, 7). 
1.1.2 The enterohepatic circulation and bile acids transporter  
Conservation of the pool size of BAs within the enterohepatic circulation 
requires the coordinate action of several transporter proteins expressed at 
the apical and basolateral membranes of liver and intestinal epithelial 
cells. Enterohepatic circulation of bile acids is fundamentally composed 
of two major processes: secretion from the liver and absorption from the 
intestine. After biosynthesis, conjugated BAs are secreted into the 
canalicular space between hepatocytes (Figure 1.3) via two ATP-binding 
cassette transporters: bile acids export pump (BSEP), that carries 
monovalent bile acids and multidrug resistance protein 2 (MRP2), that 
transports divalent bile salts, such as sulfated bile salt conjugates (8). 
Canalicular BA secretion represents the rate-limiting step in bile 
formation. Whereas BA concentrations within the hepatocyte are in the 
micromolar range, canalicular BA concentrations are more than 1,000-
fold higher, necessitating active transport across the canalicular 
hepatocyte membrane. Thus, the BAs are secreted against steep 
concentration gradients in the gallbladder and are driven by ATP 
hydrolysis. In the gallbladder, most of the bile salt pool is stored during 
the fasting state. After ingestion of a meal, the presence of fats and 
proteins in the duodenum stimulates the release of endogenous neuro-
hormones such as cholecystokinin (CCK). The release of CCK is 
correlated with contraction of the gallbladder (9). The end result is that 
Chapter 1 
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gallbladder bile is delivered to the duodenum, where the BAs carry out 
their role in emulsifying dietary lipids.  
Figure 1.3 Enterohepatic circulation of bile acids (10). 
The second important process of enterohepatic circulation is the 
absorption of BAs from the intestine. Conjugated BAs enter in the 
enterocytes by active uptake via a Na+-dependent mechanism. The apical 
sodium-dependent bile salt transporter (ASBT) (11) imports BAs coupled 
to Na+ absorption in a 1:2 stoichiometry (12). Unconjugated BAs that are 
formed by bacterial biotransformation for their elimination in faeces are 
membrane permeable and thus the absorption from the colon is a passive 
mechanism. This non-carried mediated mechanism accounts for a small 
fraction of intestinal BA conservation (13).  
Chapter 1 
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In the enterocytes, intracellular carrier proteins mediate the BAs 
transport from the apical membrane towards the basolateralal pole. Ileal 
bile acid binding proteins (I-BABP) have been proposed to act as the 
putative BA carriers in the enterocytes (14-17). 
The basolater efflux of BAs from enterocytes into the portal vein is 
mediated by the organic solute transporter α and β (OSTα-OSTβ) (18). 
OST-mediated transport requires the formation of heterodimer in which 
the two subunits α and β interact to generate a functional transporter. 
OSTα and OSTβ have been shown to transport taurine and glycine 
conjugated bile acids in addition to other sterols (prostaglandin E2, 
estrone-3-sulfate and dehydroepiandrosterone sulphate).  
Once in the portal vein, BAs associate with albumin and reach the space 
of Disse through the large fenestrea (large pores) of the liver sinusoids. 
After their dissociation from albumin, unconjugated BAs can traverse cell 
membranes by passive diffusion, while taurine or glycine conjugated BAs 
require an active transport mechanism for cellular uptake (19). Hepatic 
uptake of BAs occurs against a 5- to 10-fold concentration gradient 
between the portal blood plasma and the hepatocyte cytosol and is 
mediated by both sodium dependent and sodium-independent 
mechanisms (8, 20). Na+ dependent uptake activity has been shown to be 
predominantly mediated by Na+ dependent taurocholic cotransporting 
polypeptide (NTCP) (8, 20, 21). BAs uptake via NTCP is unidirectional 
with a sodium-to-taurocholate stoichiometry of 2:1, i.e., cotransport of 
two Na+ with one taurocholate molecule, and it is driven by a Na+
gradient that is maintained by the activity of Na+/K+ ATPase (8, 21). A 
further protein involved with NTCP in sodium-dependent bile salt uptake 
across the basolateral hepatocyte membrane is the enzyme microsomal 
epoxide hydrolase (mEH) (22). The contributions of mEH and NTCP to 
BAs transport in humans depend on the substrate specificities of these 
two transport proteins. While NTCP is able to transport taurocholate, its 
ability to transport glycocholate is significantly reduced. In contrast mEH 
is shown to transport preferentially glycocholate (23). Sodium-
independent hepatocellular uptake of bile salts is mediated by several 
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members of the family of Organic Anion Transporting Polypeptides 
(OATPs). OATPs are multispecific transporter systems that mediate, in 
addition to conjugated and unconjugated BAs, hepatocellular uptake of a 
vast variety of other amphipathic organic compounds, including 
bromosulfophthalein (BSP), bilirubin, hormones and numerous drugs (21, 
24). Human liver expresses four OATPs (OATP-A, OATP-B, OATP-C, 
and OATP8), although all with different expression levels and 
significance for BAs uptake (21, 24, 25).  
The intracellular transport of BAs from the basolateral to the 
canalicular membrane of the hepatocytes has been proposed to be 
mediated by two distinct processes: intracellular trafficking and vesicle-
mediated transport (8, 21). The intracellular trafficking represents the 
major intracellular transport process in physiological conditions, whereas 
the vesicle-mediated pathway is involved at high bile salt concentrations 
to prevent efflux from the cytosol back into the blood (21). Intracellular 
trafficking is mediated by intracellular binding proteins and it is driven by 
basolateral to canalicular BAs concentration gradient (21, 26).  
1.1.3  Physiological function of bile acids 
The first and most important BAs function is the elimination of 
cholesterol, through either the degradation of cholesterol to bile acids or 
the solubilisation of cholesterol in mixed micelles for the elimination via 
the fecal route. In the small intestine, BAs promote dietary lipid 
absorption by solubilizing lipids and their digestion products as mixed 
micelles. BAs are the most important organic solutes of bile end their 
secretion into bile represents the major driving force for bile flow. 
Another BAs function is related to the stimulation of biliary phospholipid 
secretion into bile. The presence of phospholipids in bile results in a 
greater fraction of bile acids existing in the form of mixed micelles, 
characterized by a low critical micelle concentration (CMC). A low 
monomer concentration of BAs in bile is important to prevent cell 
damage (27, 28).  
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1.1.4  Bile acids as regulatory molecules 
Besides their roles in dietary lipid absorption and cholesterol homeostasis, 
BAs are increasingly recognized as important signalling molecules in 
liver, bile ducts and the intestine. The most important role of BAs as 
regulatory molecule is their implication in the BA homeostasis. The 
maintenance of BA homeostasis is mediated by several mechanisms, 
which involve on one side the feedback regulation of BA biosynthesis and 
on the other side the expression of hepatic and intestinal transporters. In 
the liver BAs decrease their own biosynthesis through an elaborate 
feedback inhibitory circuit, which starts by BA-mediated activation of 
farnesoid X receptor (FXR) (29). The activation of FXR induces the 
expression of a suppressor protein termed SHP (small heterodimer 
partner). SHP is an atypical nuclear hormone receptor that lacks of DNA 
binding domain, but display its regulatory function when bound to other 
transcriptional factors. SHP interacts with two nuclear receptors, the 
hepatic nuclear factor 4 (HNF4) and the liver receptor homolog-1 (LRH-
1). The formation of this heterodimer complex results in the inhibition of 
the transcription of CYP7A1 (10, 30-32). A schematic representation of 
negative feedback regulation of bile acid and cholesterol biosynthesis is 
shown in figure 1.4.  
Figure 1.4 Negative feedback regulation of bile acid and cholesterol biosynthesis. Only 
the rate-limiting enzyme of biosynthesis are reported. 
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In the intestine, the activation of FXR by BAs induces also the expression 
of an intestinal hormone, fibroblast growth factor 19 (FGF19). 
Stimulation of hepatic FGF receptor 4 (FGFR4) by FGF19 leads to 
receptor dimerization, autophosphorylation and activation of mitogen-
activated protein kinase (MAPK) pathways resulting in the repression of 
CYP7A1 (30). 
Other factors, such as endotoxin, tumor necrosis factor (TNF) and 
Interleukin-1 (IL-1) are involved in cell signalling pathways that strongly 
decrease CYP7A mRNA level and activity (31). 
In addition to the regulation of synthesis FXR plays a central role also in 
the flux of BAs through the regulation of the expression of hepatic and 
intestinal BA transporters (Figure 1.5). In order to protect the cell from 
the accumulations of toxic levels of BAs, FXR stimulates BAs efflux and 
inhibits their uptake in a concerted manner. In particular, in the liver FXR 
induces the expression of BSEP (33) and MRP2 (34) to increase the BAs 
export. At the same time the over-expression of SHP, forming 
heterodimeric complex with transcription factor (RAR/RXR), inhibits the 
transcription of NTCP and thereby the basolateral uptake of BAs (35). 
Similarly, in the enterocytes the activation of FXR induces the expression 
of transporter involved in the basolater efflux of BAs, i.e. the organic 
solute OSTα and β (36) and in the intracellular carrier, the IBABP (37). 
In addition, FXR is responsible for reducing ASBT expression level and 
consequently the apical uptake of BAs (38). Thus, in the enterocytes FXR 
acts in prevention of intracellular accumulation of BAs with inhibition of 
genes involved in the intestinal absorption and activation of transcription 
of genes encoding BAs export transpoters.  
Chapter 1 
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Figure 1.5 Bile acid induced regulation of hepatic and intestinal bile acid transporters. 
Besides its roles in BA homeostasis, there are indications that BAs 
regulate gluconeogenesis, glycogen synthesis, insulin sensitivity (39) and 
lipid homeostasis mainly through activation of FXR (40, 41). BAs can 
also modulate energy metabolism increasing cAMP production. BAs bind 
TGR5, a G protein-coupled receptor (GPCR) which responds to BAs by 
inducing receptor internalization, activation of MAPK pathways, and 
cAMP production (42, 43). It has also been observed that administration 
of BAs to mice increased energy expenditure in brown adipose tissue and 
prevented development of obesity and insulin resistance (44).  
1.2 The intracellular bile acid binding proteins 
It has been proposed that specific carrier proteins might mediate the 
intracellular transport of cytotoxic BAs within hepatocytes and ileocytes 
during the enterohepatic circulation. These carrier proteins are the Bile 
Acid Binding Proteins (BABP) belonging to the Fatty Acid Binding 
Proteins (FABP) family. These are abundantly expressed 14-15 KDa 
proteins that bind with high affinity hydrophobic ligands, such as fatty 
acids, eicosanoids and other lipids (45, 46). Despite the considerable 
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differences in their primary structure, the tertiary structure of all FABPs is 
highly conserved. The common structural feature is a 10-stranded β-
barrel, made of two orthogonal antiparallel 5-stranded sheets that form the 
“clam” shaped binding cavity (47). The opening of this clam, considered 
the portal domain, is framed on one side with the N-terminal helix-turn-
helix domain, a common structural motif of all FABPs. Based on their 
primary structure and the first tissue from which they were isolated, 
FABPs have been classified into several types including heart, liver, 
intestinal, adipocyte, myelin, ileal and epidermal (48, 49). The distinctive 
pattern of tissue expression of the different FABP types, as well as the co 
expression of different FABPs in a single cell type, suggests that each 
FABP has a specific function in cellular metabolism (50).  
1.2.1  FABPs and BABPs in the hepatocytes 
In the liver, two paralogous group of FABPs have been described: liver-
FABP (L-FABP), extensively characterized in mammals, and liver-BABP 
(initially called liver basic-FABP) that has been described in several non 
mammalian vertebrates, but has not yet been found in mammalian liver 
(51). The degree of amino acid identity between two subgroups range 
from 39% to 42%. Mammalian L-FABP, which binds a broad range of 
ligand molecules (acyl-CoAs, heme, squalene, bilirubin and certain 
eicosanoids), is the only FABP that forms a complex with two fatty acid 
molecules at the same time (Figure 1.6), whereas all the other members of 
the FABP family have a single fatty-acid-binding site (52-54). Recently 
NMR binding experiments indicated clearly that hL-FABP is able to bind 
not only fatty acid, but also glychochenodeoxycholic acid, one of two 
most abundant physiological BAs. It has been suggested that hL-FABP is 
involved in the physiological regulation of fatty acid and bile acid 
metabolism (51). Therefore this protein has been proposed to be the 
hepatic cytosolic bile acid carrier in humans.  
Chapter 1 
21 
Figure 1.6 Three dimensional crystal structure of rat liver FABP in complex with two 
molecules of oleate (PDB 1LFO). The first molecule of fatty acid is coordinated in a 
bent conformation with its carboxylate shielded from free solvent (blue molecule). The 
second fatty acid adopts a rather linear shape with the acyl chain in the cavity interior 
and the carboxylate more exposed to the solvent (red molecule). 
All the non-mammalian liver BABPs studied so far have shown to 
bind BAs with a stoichiometry of binding of two BA molecules per 
protein molecule. L-BABPs have been identified in birds (55-57), 
amphibians (58-60), reptiles (61), and fish (62-67). X-ray crystallography 
and NMR spectroscopy have been used to experimentally determine the 
three-dimensional structure of some BABPs in their apo and holo forms 
complexed with BAs. The best-characterized member among them is 
chicken BABP (cL-BABP), able to bind cholic (CA), chenodeoxycholic 
acid (CDA) and their glycine conjugated (68-70). The 3D structures of 
cL-BABP in complex with CA and CDA, resolved by X-ray and NMR 
spectroscopy, respectively, are reported in figure 1.7. Several NMR 
studies have shown that cL-BABP binds two molecules of BA with high 
affinity and high cooperativity. Furthermore the binding event is 
accompanied by a global structural rearrangement, possibly triggered by 
the protonation of a buried histidine, which suggests an allosteric 
mechanism at the basis of the cooperativity (70-72). This mechanism 
implies the presence of a dynamic ensemble of conformations in the apo 
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form. The ligand has thus the capability of selecting one existing 
conformation shifting the equilibrium towards the most stable holo form.  
Figure 1.7 Three dimensional structure of cL-BABP in complex with two molecules of 
cholic acid (green, PDB code:1TW4) and chenodeoxycholic acid (red, PDB code:2JN3). 
1.2.2 BABPs in the enterocytes 
Intracellular transport of BAs, in enterocytes, is mediated by ileal BABPs 
(I-BABP). Differently from liver BABPs, these proteins have been 
identified in several mammalian species, and recently in the ileum of non-
mammalian vertebrates (51, 73). The interaction of human I-BABP (hI-
BABP) with different BAs has been extensively characterized. hI-BABP 
binds two molecules of GCA with low intrinsic affinity but an 
extraordinarily high degree of positive cooperativity. In this case the Hill 
coefficient, a parameter commonly used to estimate the cooperativity, is 
very high (nH = 1.94), where 2 is the maximum value for an extremely 
positively cooperative two-site system (15). It has been reported that the 
binding cooperativity of hI-BABP with several physiologically BAs (CA, 
CDA, DCA and their glycine or taurine conjugated) is governed by the 
pattern of steroid rings hydroxylation and not by presence or type of side-
chain conjugation (74). In addition to the strong positive cooperativity, hI-
BABP has been found to exhibit a high degree of site selectivity in its 
interaction with GCA and GCDA. When hI-BABP is complexed with 
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either GCA or GCDA alone, the ligands bind to both sites. When the 
protein is mixed with an equimolar mixture of the two BAs, GCDA binds 
exclusively to one site (named site 1) and GCA to the other (named site 
2). This remarkable selectivity is governed by the presence or absence of 
a single hydroxyl group at the C-12 position of the steroid nucleus (75). 
Furthermore it has been shown that cooperativity and site selectivity are 
not linked in the protein. Mutations that results in diminished binding 
cooperativity (N61A, Q99A, E110A and W49Y) do not show any 
substantial loss in site selectivity, and the only mutation that results in the 
loss of site selectivity (Q51A) exhibits no decrease in binding 
cooperativity (76). The characteristics of positive-binding cooperativity 
and site selectivity in hI-BABP report on its biological function. In the 
human body, approximately 55% of bile salts have three and 
approximately 35% of bile salts have two hydroxyl groups on their steroid 
ring system. Because of the relatively low intrinsic affinities of I-BABP 
for both GCA and GCDA, at a low bile salt concentration, a sizable 
fraction of bile salts remain unbound (passing through the enterocytes as 
monomers). When the bile salt concentrations increases, the strong 
cooperativity allows that the fraction of unbound glycholate decreases as 
the BA:protein ratio increases, thus protecting the cells from bile salt 
toxicity (e.g., apoptosis) On the other hand, the site selectively ensures 
that the majority of hI-BABP complexes in vivo are heterotypic: they 
contain both glycocholic acid (GCA) and glychochenodeoxycholic acid 
(GCDA) . Thus, with the combination of site selectivity and positive-
binding cooperativity, nature engineered hI-BABP to be a highly efficient 
regulator that may function as a “regulated sponge” able to recognize 
structurally diverse BAs that exist in the human body (15, 76). A 
structural model of the heterotypic complex obtained by docking the 
ligands into the protein using NOE-derived inter-proton distance restraints 
has been described by Toke et al. (76) and is shown in figure 1.8. 
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Figure 1.8 Homology model of hI-BABP with GCA and GCDA docked by restrained 
energy minimization. 
Interestingly, the model reported for the ternary complex of hI-BABP 
with GCA and GCDA shows an apparent discrepancy with the previous 
reported NMR structures of human and porcine I-BABP in complex with 
BA (16, 17). The structure of human I-BABP has been solved in complex 
with cholytaurine (PDB code 1O1V), while the porcine protein in 
complex with GCA (PDB code 1EIO). In both cases the proteins bound 
inside the cavity a single BA molecule. The different binding 
stoichiometry could be explained by the temperature dependence of 
ligand exchange rates. Indeed both structures were determined at 
temperatures above 30°C, where one of the two glycocholate binding sites 
may have been undetected because of NMR exchange broadening (15). 
Recently, calorimetry and ESI-MS studies of rabbit I-BABP (rI-BABP), 
highly homologous to the hI-BABP, have demonstrated that the protein is 
able to bind three BA molecules. Two molecules are bound inside the 
protein cavity, while a third binding site is hypothesised on the 
hydrophobic molecular surface. Besides, the observation of high affinity 
binding of the rI-BABP for taurine and glycine-conjugated DCA, appears 
to correlate with its biological function. Indeed DCA is by far the most 
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abundant ligand (90%) in the bile acid pool of rabbits (77). Thus, the 
difference in ligand binding stoichiometry may correlate with species-
specific differences in ligand abundance in the diet. 
An example of multiple binding has been found also in the non-
mammalian zebrafish I-BABP (zI-BABP). The X-ray structere of zI-
BABP has been solved in the apo and holo form, complexed with cholic 
acid. The structure of the holo protein shows two cholate ligands bound in 
the internal cavity and several cholate molecules bound on hydrophobic 
patches on the surface of the protein (Figure 1.9). Isothermal Titration 
Calorimetry (ITC) has confirmed the presence of multiple ligands (73). 
Figure 1.9 Crystal structure of zebrafish I-BABP complexed with cholate solved from two 
crystal forms. (a) Ribbon representation of the holo protein of crystal form A (PDB code 
3ELZ). (b) Ribbon representation of the holo protein of crystal form B (PDB code 3EM0). 
Internal cholate molecules are coloured in red, external molecules are coloured in cyan.  
1.3    Magnetic resonance imaging and gadolinium contrast agent 
Clinical magnetic resonance imaging (MRI) relies on the magnetic 
properties of 1H, as one of the most abundant naturally occurring nuclei in 
the human body. Spatial information about the distribution of magnetic 
nuclei in the body is achieved by exposing them to an inhomogeneous 
magnetic field that varies linearly over the body, forming a so-called 
magnetic field gradient. The magnetic field gradient causes identical 
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nuclei to precess at different Larmor frequencies, which are proportional 
to the field strength. The larger the gradient strength the larger the frequency 
range, and thereby the characteristically outstanding contrast between 
various anatomic structures in the human body is obtained by MRI.  
The term contrast defines the relative difference in intensities between 
two adjacent regions within an examined object. The contrast of an MR 
image is the result of various contributing intrinsic parameters, such as 
the proton longitudinal relaxation times (T1), the proton transverse 
relaxation times (T2) and the proton density, and extrinsic parameters, 
such as the type of pulse sequence, the timing parameters of the pulse 
sequence and the strength of magnetic field. The diagnosis of several 
pathologies by MRI requires the involvement of contrast agents (CAs) 
that can enhance the difference between normal and diseased tissues by 
modifying their intrinsic parameters. The ability of a CA to influence the 
relaxation times of the surrounding water protons is related to its intrinsic 
imaging property, i.e. the relaxivity (r1 and r2, refer to longitudinal and 
transverse relaxivity, respectively). The relaxivity is defined as the 
relaxation enhancement of water protons produced by 1 mmol per liter of 
CA (expressed in s−1 mmol−1 l). The observed relaxation rate, upon 
addition of a paramagnetic CA, is given by the sum of the diamagnetic 
and paramagnetic contributions (Equation 1.1). The water relaxation rates 
are linearly dependent on the concentration of the CA, with a slope given 
by the relaxivity (Equation 1.2). 
(1/Ti)obs = (1/Ti)diamagnetic + (1/Ti)paramagnetic i = 1,2    (1.1)  
(1/Ti)obs = (1/Ti)diamagnetic + ri[CA]                       i = 1,2    (1.2)  
where: 
(1/Ti)obs = (Ri) obs = global relaxation rate  
(1/Ti)diamagnetic = relaxation rate before addition of the CA 
(1/Ti)paramagnetic = relaxation rate due to presence of CA 
ri = the relaxivity  
[CA] =  concentration of contrast agent 
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A higher relaxivity means more efficient proton relaxation rate 
enhancement, and hence, compounds with high relaxivity can be detected 
at lower doses, or provide greater contrast at equivalent doses. In this line, 
the relaxivity has to be the primary requisite in the design of new CAs. 
The relaxivity depends essentially on the size and chemical structure of a 
paramagnetic CA molecule and on the accessibility of water molecules to 
the paramagnetic centre (78). Among these factors, the most important 
parameter influencing relaxivity is the tumbling rate of the CA complex. 
The molecular motion of the complex can be slowed down by the 
formation of covalent or non covalent conjugates between the 
paramagnetic complex and slowly moving substrates, such as proteins 
(79), micelles (80), polyaminoacids (81), polysaccharides (82) or 
dendrimes (83). In these supramolecular systems, the tumbling rate of the 
paramagnetic complex decreases with a concomitant increase in the 
relaxivity. 
The commonest and most frequently used agents for obtaining clinical 
imaging are low-molecular-weight gadolinium (Gd) chelates. The use of 
paramagnetic complex based on the presence of Gd ion is due to its high 
paramagnetism (seven unpaired electrons) and its favourable properties in 
terms of electronic relaxation (slow electronic relaxation time). Since free 
Gd ions are strongly toxic in the human body, they must be chelate by 
compounds that form very stable chelates (84). For clinical application, 
the Gd complex, such as all CAs, should fulfil several other requirements, 
such as low toxicity (high thermodynamic and kinetic stability), rapid 
excretion after administration, good water solubility and low osmotic 
potential of the solutions clinically used (85).  
1.3.1 Bile acids-derived contrast agents for MRI of the liver 
The contrast agents used for MRI of the liver were designed to improve 
the discrimination and diagnosis of focal hepatic lesion. In the past, 
paramagnetic extracellular CAs (e.g. Gd-DTPA or Gd-DOTA) were used 
to improve the differential diagnosis, but after intravenous administration 
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they were rapidly distributed in the interstitial space and eliminated 
almost exclusively through the kidney (86). Hepatospecific CAs were 
subsequently developed, where a lipophilic residue was conjugated to the 
Gd-chelate (Figure 1.10). These “lipophilic complex” are the CAs 
currently used in clinical imaging of the liver and include gadobenate 
dimeglumine (Gd-BOPTA; MultiHance, Bracco Imaging, Milan, Italy), 
and gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-
EOB-DTPA; Primovist, Bayer-Schering Pharma, Berlin, Germany). 
Figure 1.10 Chemical structure of different CAs. Gd-EOB-DTPA (87) and Gd-BOPTA 
(88) contain a Gd-DTPA complex linked to a different lipophilic residue. 
The lipophilic complexes are efficiently internalized in the hepatocytes, 
but they are rapidly eliminated by biliary excretion, although the primary 
route of elimination is renal (89). Similarly to bile acids enterohepatic 
circulation, the excretion of Gd-BOPTA and Gd-EOB-DTPA into bile is 
mediated by active transport in which MRP proteins are involved (90). 
The active uptake of CAs through the basolateral membrane of 
hepatocytes is driven by OATPs. Interestingly, it was shown that OATPs 
are not expressed in the basolateral membrane of some hepatoma cell 
lines, thus making these lipophilic complexes diagnostic of specific 
hepatic malignancies (91). In this line, several Gd complexes conjugated 
to different bile acids (e.g. CA, CDA, DCA) were prepared and 
investigated as possible hepatospecific CAs. Among the most promising 
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compounds, some molecules, in which the Gd complex was linked to the 
position 3 of the steroid moiety of the bile acid, showed high biliary 
elimination as well as good tolerability (92, 93). The first of these 
compound (Figure 1.11) to be under clinical development has been the 
gadocoletic acid trisodium salt (laboratory code B22956/1).  
Figure 1.11 Chemical structure of B22956/1. The Gd-DTPA complex is linked to 
deoxycholic acid (DCA) through a flexible spacer. 
1.3.2 L-BABP as possible CA-carrier 
To further improve MRI performance it is crucial that CAs are developed 
with optimal organ specificity. This will not only result in a better 
diagnostic efficiency but also in a reduction of the amount of the agent 
administered. The organ targeting is based on the understanding of the 
mechanism involved in the interaction of the agent with proteins, as well 
as the membrane transporters or carrier proteins. Because the 
pharmacokinetics of each compound plays a fundamental role in its 
contrast enhancement effects, the understanding of the structure of a CA 
when bound to a macromolecule is a necessary step to set the basis for the 
rational design of more efficient hepatospecific CAs. While a few studies 
have addressed the cellular uptake and excretion of bile acid-derived CAs 
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in the liver, little is known about the mechanism of intracellular transport. 
Recently we have investigated (94) the interaction between a model 
BABP protein and some adducts in which Gd-DTPA was linked to 
different bile acids. From a preliminary analysis based on binding affinity 
and relaxivity, the better complex could be selected (Figure 1.12). The 
adduct between chicken liver BABP and Gd-DTPA-conjugated to 5β-
cholanoic acid (named Gd-1) exhibited high relaxivity and the highest 
affinity toward the protein. 
Figure 1.12 Structure of Gd-DTPA conjugated to 5β-cholanoic acid used to address the 
interaction with BABP. 
We found, on the basis of a wide variety of NMR experiments, that Gd-1 
is able to bind the intracellular carrier protein with a protein:ligand 
stoichiometry of 1:1 and reasonably good affinity (in the micromolar 
range). The portal region of the protein constitutes the binding site for the 
bile acid derived CA with the Gd-DTPA moiety of the ligand that remains 
outside the protein cavity.

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Protein–ligand interactions play an essential role in many biological 
processes such as signal transduction and cell regulation and represent 
important targets for engineering and design efforts. In general, the 
biological function of a protein depends on its interaction with ligand 
molecules. Accordingly, it is clear that understanding biological functions 
requires a precise knowledge about the structure of protein–ligand 
complexes. Nuclear magnetic resonance (NMR) spectroscopy for protein 
structure determination is now firmly established as an alternative method 
beside X-ray crystallography. NMR can give a detailed picture of the 
three-dimensional structure of a protein in solution at atomic resolution. 
Furthermore, NMR allows studying conformational dynamics, real time 
enzyme kinetics, and very week to tight protein-protein and protein-
ligand interactions.  
The traditional NMR approach to solving protein-ligand complexes 
requires the collection of intramolecular distances of the protein (nuclear 
Overhauser effect (NOE) distances) and a reasonable number of 
intermolecular NOE distances between the protein and ligands. In full 
structure determinations of protein–ligand complexes, intermolecular and 
intra-ligand NOEs can usually be treated in the same manner as NOEs 
within the protein. Standard ab initio simulated annealing based on 
Cartesian coordinate or torsion-angle dynamics (e.g. CNS (95)) usually 
work satisfactorily. On the other hand, given the intrinsically poor 
chemical shift dispersion of the methine and methylene proton resonances 
of some small aliphatic ligands (such as bile acids, studied in this thesis), 
it is often difficult or impossible to derive many intermolecular restraints 
or to obtain proton ligand assignments directly from the experimental 
data. A strategy is using ambiguous intermolecular restraints derived from 
other NMR experiments that can supplement the initial restraints list of 
intermolecular restraints in order to obtain a preliminary protein-ligand 
structure by guided docking approach. At this point, starting from the 
preliminary structure model, it is possible to identify further protein-
ligand interactions. The latters can help in the interpretation of unassigned 
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protein-ligand NOEs and enrich the restraints list. Then, using an 
interactive procedure, the structural models calculated by docking 
approach can lead to the identification of a reasonable number of 
intermolecular restraints and subsequently to the structural determination 
of the complex with high accuracy. 
In the last decade, several computational approaches have been used in 
order to help in predicting protein-protein and protein-ligand interactions 
and to solve protein–ligand structures. Among the current docking 
methods, HADDOCK (High Ambiguity-Driven DOCKing) distinguishes 
itself from others by the use of experimental and/or bioinformatics data to 
drive the docking process. In particular HADDOCK allows obtaining 
high resolution structures of  the protein-ligand complex starting from the 
known 3D structure of the protein and incorporating information on 
distance constraints between the protein and the ligand obtained 
experimentally by NMR. Thus ambiguous intermolecular restraints, such 
as chemical shift perturbation (CSP), 15N relaxation measurement data, 
and unambiguous intermolecular restraints such as intermolecular NOEs 
(96, 97) can be used to drive the docking. Furthermore, if the structure of 
the protein undergoes structural rearrangement upon formation of a 
complex with a partner, significant improvement of the docking approach 
is achieved if the structure of the holo protein (without ligand) is used as 
starting structure instead of the one corresponding to the apo protein or 
modeled structure (98). 
In this line, the structure determination of protein complexes by NMR in 
combination with docking approaches, involves several steps. These are 
summarized in Scheme 2.1.  
This chapter describes the methods, the NMR experiments and the 
software used in my research project for determining the three-
dimensional structures of a protein-ligand complex following the 
procedures outlined in the scheme. 
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) Flow chart of the procedure for deriving 3D protein-ligand structures using 
experimental NMR data in conjunction with docking approach. 
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Structural studies require high-level expression systems and efficient 
purification protocols. Escherichia Coli is the one of the most successful 
host systems for high-level production of both prokaryotic and eukaryotic 
proteins. Moreover, expression in E.coli is often the most favoured 
method because of the ease of expression and high label incorporation 
into the recombinant protein. 
In my thesis work I performed the expression and purification of two bile 
acid binding proteins, the chicken liver BABP and the chicken ileal BABP 
and some mutants of the latter. For all the proteins, wild type and mutants, 
the protocols used are the same, with slight differences. 
For unlabelled proteins, a 10 ml starter culture of the best expression 
colony was grown in LB medium shacking overnight at 37°C. The culture 
was used to inoculate 1L of LB, then incubated in a shaker at 37°C till an 
OD600 value of 0.6 was reached. Protein expression was induced by the 
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addition of IPTG (Isopropyl -D-thiogalactoside). The cells were allowed 
to grow overnight at the best temperature. After harvesting, the cells were 
lysed by sonication and the supernatant, containing the soluble protein 
fraction, was loaded on the first purification column. The 15N or 15N-13C 
labelled proteins were expressed in M9 minimal media, containing 
15NH4Cl for uniformly 15N labelled samples or 15NH4Cl/13C-glucose for 
uniformly 15N/13C labelled samples using the same expression protocols 
of unlabelled proteins.  
The purification started with an anion exchange chromatography followed 
by a size exclusion chromatography with a final delipidation step. The 
isolated proteins were transferred, by dialysis, in a buffer solution optimal 
for NMR measurements and finally processed by liophylization and 
stored at 4°C. 
Protein concentrations were estimated from the extinction coefficients at 
280 nm as calculated using the ProtParam tool (http://expasy.ch/ 
protparam) of the Swiss Institute of Bioinformatics.  
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In the case of labelled protein samples, mass spectrometry analysis was 
performed to estimate the 15N and/or 13C isotope inclusion percentage. In 
addition every unlabelled protein was checked by 1H mono-dimensional 
NMR experiment. For single or double-labelled proteins basic two-
dimensional heteronuclear NMR experiments were performed to confirm 
the isotope inclusion and to evaluate the quality of the protein 
preparation. 
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For NMR analysis liophylized samples were prepared by suspending the 
freeze-dried protein in 90% H2O/10% D2O or 100% D2O. NMR 
experiments were performed on 0.4-0.8 mM samples depending on 
experimental requirements. The NMR experiments were recorded on a 
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Bruker Avance III 600 spectrometer, operating at 600.13 MHz proton 
Larmor frequency, equipped with a triple resonance TCI cryoprobe, 
incorporating gradients in the z -axis. The experimental temperature was 
set to 298 K, unless otherwise specified. 
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NMR methods for the study of protein structures depend on the variation 
of the resonance frequency of a nuclear spin, in an external magnetic 
field, with the different chemical structure, conformation, and solvent 
environment. Three of the four most abundant elements in proteins, H, C, 
and N, have naturally occurring isotopes with nuclear spin 1/2 which are 
suitable for high-resolution NMR experiments in solution. The proton 1H 
has the highest natural abundance (99.98%) whereas both 13C and 15N 
have low natural abundance (1.11% and 0.37% respectively). The lower 
abundance of 13C and 15N is routinely overcome by over expression of 
proteins in isotope-labelled media.  
The nuclear spin gives rise to a magnetic dipole moment: 
=  I                               (2.1) 
where  is magnetic dipole moment,  is gyromagnetic ratio of the 
nucleus and I is spin angular momentum. If such an atomic nucleus is 
placed into external magnetic field B0, it has energy associated with the 
interaction between its magnetic moment and the external field: 
                          E = - B0 = -  I B0                   (2.2) 
In the absence of a magnetic field a collection of nuclear spins can adopt 
all possible spatial orientations. When placed in a magnetic field magnetic 
moments of spin 1/2 nuclei assume two orientations (Figure 2.1), either in 
the same direction or in the opposed direction with respect to the 
magnetic field. At thermal equilibrium, the population distribution for a ½ 
spin nucleus, can be calculated by using the Boltzmann distribution 
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relationship:  
          KT
E
lower
upper e
N
N 
   (2.3) 
where N is the population in each state, T is the absolute temperature in 
Kelvin and k is the Boltzmann constant.  

.) Orientation of nuclear magnetic dipoles in the absence of magnetic field (A) 
and in presence of a magnetic field Bo along the z-axis (B) (99). 
 
Since the lower level is slightly more populated than the upper level, at 
the thermal equilibrium the sample has a net magnetization M0 (Figure 
2.2) in the direction of the magnetic field B0 (along the z-axis). Because 
the magnetization aligned along the z-axis is undetectable, in order to 
induce nuclear magnetic resonance, the equilibrium condition of M0 has 
to be perturbed. This is achieved by applying an additional magnetic field 
(B1) along the x axis, which rotates the magnetization into the x,y plane 
perpendicular to B0. 
 
.) The equilibrium condition of the magnetization aligned along the z-axis (M0) 
is perturbed by B1 applied along the x axis. The magnetization rotated into the xy plane 
precesses at the Larmor frequency. In the NMR experiment the precession of the 
magnetization vector in the xy plane is detected by a coil. 
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The transverse magnetization in the xy plane precesses under the 
influence of the static magnetic field B0 at the Larmor frequency ( 0 or 
resonance frequency). The Larmor frequency is described by the 
following relationship: 
                     
	


2
0
0
B
        or       00 B             (2.4) 
where 0 refers to the frequency expressed in Hertz (Hz), while 0 refers 
to the frequency in rad s-1. 
The precession of the magnetization vector in the xy plane induces an 
electric current in a detection coil, which is the primary observation in a 
NMR experiment. 
Since the system tends to return to its equilibrium condition with the 
magnetization orientated parallel to B0, the acquired signal decreases 
during time: this is the so-called free induction decay (FID). The NMR 
spectrum is then obtained by Fourier transformation (FT) of this data 
(Figure 2.3).  

.)# The Fourier transformation of the NMR signal. NMR signal is free-induction 
decay (FID) which is a function of time, F(t). The Fourier transformation is used to 
translate the function from the time domain into the frequency domain, F(). 
 
In a NMR spectrum, each resonance (frequency line) represents one or 
more nuclei. As stated before, the NMR frequency of a nucleus in a 
molecule is determined by its gyromagnetic ratio  and by the strength of 
the applied magnetic field B0 (Equation 2.4). However not all protons, nor 
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all 13C nuclei, have identical resonance frequencies since  depends on the 
chemical environment of nucleus. This effect is called chemical shift () 
and is generally defined as the difference between the resonance frequency 
of the nucleus of interest () and that of a reference nucleus ( ref): 
 
ref
ref







                              (2.5) 
The frequency difference -ref is divided by ref so that  is a molecular 
property, independent of the magnetic field used to measure it. 
The chemical shift is a fundamental parameter in protein NMR as it gives 
separately detectable signals for the hundreds of protons (or other NMR 
nuclei) that can therefore be distinguished and assigned. This allows the 
identification of signals from individual atoms even in complex biological 
macromolecules. Thus from the resulting spectra it is possible obtain 
information on molecular structure, conformation and dynamics. 
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The typical scheme of a 1D experiments is shown in figure 2.4. 
 
 
.)$ Scheme of a 1D NMR experiment 
 
Each 1D NMR experiment consists of two sections: preparation and 
detection. Preparation is the time needed before the system reaches 
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equilibrium when immersed in the static magnetic field B0. After the 
equilibrium magnetization (M0) has been established, a radiofrequency 
pulse is applied. The 90° pulse (applied along the x axis) rotates the 
magnetization onto the perpendicular axes. After this pulse each spin 
precesses with its own Larmor frequency around the z axis and induces a 
signal in the receiver coil. During detection the resulting signal is 
recorded. A receiver, located in a direction perpendicular to the vector B0 
direction, acquires the signal with an intensity that is proportional to the 
magnetization in the xy plane. The behaviour of the magnetization decay 
(FID) is detected during the time T2, which is the necessary time so that 
the transverse magnetization reaches the equilibrium state. 
The 1D NMR spectra of biopolymers are dramatically crowded and 
complex, as it can be seen in figure 2.5, where the 1D 1H-NMR spectrum 
of a 14000 Da protein is reported. The large overlap in the proton 
resonances exclude any chance for a detailed structural study. To 
overcome the natural limitation of the 1D NMR spectroscopy, 
multidimensional 2D, 3D and 4D NMR experiments have been developed 
in the last twenty years. A brief description of the 2D and 3D NMR 
spectroscopy is reported below. 
 
.)% 1D 1H-NMR spectrum of chicken L-BABP recorded at 600 MHz.. 
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A 2D NMR general scheme experiment is shown in figure 2.6. It includes 
four successive time periods: preparation, evolution, mixing and 
detection. As well as in the 1D NMR experiment, in the preparation step 
the spin system reaches the equilibrium state with the external magnetic 
field B0. The preparation ends when one or more pulses are applied and 
the system is led to a non-equilibrium state. The evolution time t1, is the 
period where the system spontaneously evolves according to the 
individual precessional frequencies. The evolution time is an 
incrementable delay and a characteristic feature of all 2D pulse 
sequences. Data acquisition includes a large number of spectra that are 
acquired as follows: the first time the value of t1 is set close to zero and 
the first spectrum is acquired. The second time, t1 is increased of t and 
another spectrum is acquired. This process is repeated until there is 
enough data for analysis using a 2D Fourier transform. 
 
.)0 Scheme of a 2D NMR experiment 
 
During the detection period a FID is recorded for each value of t1. In this 
context the real time variable that defines the FID itself is given by the 
symbol t2. The pulse sequences are designed so that the signals detected 
in t2 are modulated in amplitude or phase as a function of the delay t1. The 
different correlations between the spins are realised during the mixing 
time. Therefore the frequencies of the signals present during t1 can be 
measured indirectly through their effect on the real-time signals detected 
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directly in t2. Once the complete data set has been acquired, a Fourier 
transform with respect to t1 and t2 is used to produce a two-dimensional 
spectrum that is function of two frequencies variables F1 and F2. The 
various 2D experiments differ in the type of signals that is present during 
t1 and in the interaction employed during the mixing time to transmit 
information from t1 to t2. 
The majority of homonuclear experiments, in which are observable the 
correlations of the same isotope (usually 1H) have a common structure: 
the diagonal peaks correspond to those of the conventional one 
dimensional spectrum, while the off-diagonal peaks, or cross peaks, 
contain information about the connections between resonances on the 
diagonal. The nature of these connections depends on the kind of two 
dimensional experiment being carried out. The experiment can be set up 
to observe the scalar correlations through bonds (J-coupled) between the 
resonances of the nuclei separated by two or three bonds, (e.g. COSY and 
TOCSY), or dipolar connections (through-space), between the resonances 
of nuclei which are close together in space (e.g. NOESY). Beside the 2D 
homonuclear experiments, several experiments involving magnetization 
transfer between heteronuclei has been developed. One of the most 
popular is the Heteronuclear Single Quantum Correlation (HSQC) 
experiment which has a wide diffusion in protein NMR. In the HSQC 
experiment the magnetization is transferred from the proton nuclei to the 
heteronuclei (X= 15N or 13C) and then back to 1H for detection. This step 
is very important to enhance the sensitivity of the experiment since 15N 
and 13C heteronuclei have 300 and 32 fold less sensitivity, respectively, 
than protons. The HSQC experiment (Figure 2.7) starts with an INEPT 
(Insensitive Nuclei Enhanced by Polarization Transfer) sequence that 
transfers the magnetization from the proton to less sensitive spin directly 
attached via one bond (1JHX) scalar couplings. 
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.)1Pulse sequence diagram for HSQC experiment. 
 
This first step is followed by the evolution period during which the 
magnetization evolves under the heteronucleus chemical shift. In the 
middle of the evolution period a 180° pulse is applied at the proton 
frequency that refocus the evolution due to J-coupling. A second INEPT 
step, also called reverse INEPT, transfers back to the proton the 
magnetization which carries now the modulation due the heteronucleus 
chemical shift. At the end of this second INEPT the signal is acquired and 
recorded. During the acquisition time a decoupling pulse sequence is 
applied to the heteronucleus that remove the coupling and allows to 
obtain a single signal for every J-coupled pair of spins. The global 
appearance of an HSQC spectrum is a series of dot signals characterized 
by two frequency coordinates, i.e., proton and heteronucleus. In figure 2.8 
is reported an HSQC spectrum acquired on a 15N labelled protein. 
  
 
.)2Example of an 1H-15N HSQC spectrum. 
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A general scheme for a 3D NMR experiment is reported in figure 2.9.  
 
.)3Scheme of a 3D NMR experiment 
 
A three dimensional NMR experiment can easily set up based on a two 
dimensional scheme inserting an additional indirect evolution time and 
second mixing period before the direct data acquisition. Therefore, in a 
3D experiment the signal, which is monitored during the acquisition time 
t3, is function of two evolution times, t1 and t2, which are incremented 
independently. The signal is a matrix with three axes corresponding to t1, 
t2 and t3. After Fourier transformation, the resulting 3D spectrum is a cube 
with three different frequency dimensions F1, F2, F3. There are two 
principal classes of 3D experiments: 
 3D double-resonance experiments, which consist of two 2D 
experiments, one after another (e.g. 3D NOESY-HSQC, HCCH-
TOCSY); 
 3D triple-resonance experiments, which consist of a 2D heteronuclear 
experiments which is then extended into a different third dimension 
(e.g. 3D CBCANH, HNCO). 
 
)# 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In order to define the three dimensional structure of a protein or 
determine how it interacts with ligands, it is necessary to assign the NMR 
resonances. The goal of resonance assignment is to uniquely associate 
each nuclear spin of the sample molecule with a chemical shift observed 
in the MNR spectrum.  
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The conventional assignment strategy for unlabelled proteins (100) makes 
use of a combination of COSY/TOCSY and NOESY spectra. The first 
two experiments, based on the scalar coupling, are used to assign intra 
residue correlations between protons of same residue. A NOESY 
experiment is used to establish sequential correlations between protons of 
adjacent residues. However in 2D spectra of proteins with more than 
about 80 amino acids resonance overlap becomes so severe, that it is often 
impossible to identify all sequential correlations. The introduction of 
three-dimensional NMR experiments and the availability of 15N13C 
labelled proteins allow assigning the proton, nitrogen and carbon 
chemical shifts and to determine their structures in solution. The 
heteronuclear triple-resonance experiments (101) correlate backbone 
(1HN, 15N, 1H, 13C and 13CO) and side chain spins (1H and 13C) by an 
efficient transfer of magnetization. The magnetization is transferred via 
one bond (1J) or two bond (2J) scalar couplings. Also, since the 1J- and 2J-
couplings are generally larger than line width of nuclei under 
consideration, the coherence transfer via these couplings remain efficient 
for relatively large molecules with short transverse relaxation times and 
can compete with loss of magnetisation as a result of relaxation during the 
pulse sequence. Moreover 1J- and 2J-couplings are largely independent of 
conformation.  
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The first step in a structure determination by NMR spectroscopy of a 
doubly labelled protein is the assignment of the backbone resonances. In 
table 2.1 are summarized the triple resonance experiments used for 
backbone and side-chain resonance assignment performed in this thesis, 
with the corresponding observed correlations and the scalar couplings 
utilized for coherence transfer. The nomenclature for these triple-
resonance experiments reflect the magnetization transfer pathway of the 
experiment. Nuclei that are involved in the magnetization transfers define 
the name of the experiment while the names of nuclei which are used only 
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for transfer and whose frequencies are not detected are bracketed.  
 
-
) Triple resonance experiments used in this work for resonance assignment. 
 
The backbone assignment is achieved by combining pairs of 
heteronuclear NMR experiments, one of which provides intra-residual 
correlations between backbone resonance frequencies and the other one 
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inter-residual correlations of the same set of frequencies. 
The most important pair consists of the HNCA (101-103) and the 
HN(CO)CA (102, 104) experiment. In the HNCA experiment, the 
coherence is transferred from the amide proton (1HN) to the directly 
attached nitrogen atom (15N), which is measured as the first spectral 
dimension. Then the magnetization is transferred to the 13C alpha nucleus 
(13C) which is measured as second dimension. Afterwards, the 
magnetization is transferred back the same way to the 1HN, which is 
measured as the third (direct) dimension. Since the coupling constant 
15N(i)-13C(i) is very similar to the one between 15N(i)-13C(i-1), two 
correlations will be obtained for the amide proton, one with its own 
C(13C(i)) and other one (less intense if the delay has been fitted to the 
first coupling) with the C of the previous residue (13C(i-1)). The 
resulting NMR spectrum consists of two peaks with same 1HN, 15N 
frequencies (of residue i) but different 13C frequency, one of residue i 
and the other one of preceding residue (i-1). 
The HN(CO)CA experiment correlates the resonances of 1HN and 15N of 
the residue i only with 13C of the preceding residue. In the HN(CO)CA 
experiment the coherence transfer pathway starts from 1HN, it is passed to 
15N and then to the carbonyl spin (13CO), which suppresses the intra-
residual pathway and keeps only the inter-residual one. In this experiment 
the frequency of the 13CO spin itself is not recorded but is only used to 
transfer the coherence to the 13C(i-1). After chemical shift evolution of 
the 13C, the magnetization is transferred back via 13CO to 15N and 1HN 
for detection. The HN(CO)CA spectrum shows, instead of two peaks, 
only one with the 1H, 15N frequencies of amino acid i and the 13C 
frequency of the preceding residue. The combination of HNCA and 
HN(CO)CA experiments, therefore, allows one to distinguish between the 
intra-residual and the inter-residual 13C chemical shifts. A schematic 
representation of HNCA/HN(CO)CA spectra and the observable 
correlations is reported in figure 2.10. 
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.)5Series of strips from HNCA (left) and HN(CO)CA (right). The x and y-axes 
represent the 1HN and 13C frequencies respectively. The 15N chemical shift for each 
plane (third dimension) is noted at the bottom of the strips. In the HNCA spectrum are 
shown the correlations observed between the amide proton and the 13C of the same 
residue and the preceding amino acid 13C(i-1). In the HN(CO)CA are observable only 
the correlations of 1HN with the alpha carbons of preceding residue 13C(i-1). 
 
A second pair of experiments that give additional information to complete 
backbone assignment consists of HNCO/HN(CA)CO experiments. The 
HNCO (101, 102, 105) experiment correlates the chemical shifts of 1HN 
and 15N with the resonance of the 13CO of the same residue. 
Magnetization is passed from 1H to 15N and then selectively to the 
carbonyl 13C via 1JNCO coupling. Magnetization is then passed back along 
the reversed path for detection. The HNCO yields exclusively a single 
peak with 1H 15N frequencies of residue i and the frequency of 13CO of i-1 
residue. Besides the HN(CA)CO (106) provides intra-residue correlations 
between the 1HN, 15N and 13CO chemical shift using the one-bond 15N-
13C and 13C-13CO J-couplings (1JNCand 1JCCO respectively) to 
transfer the coherence. In addition, this experiment can also provide 
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sequential connectivities from the 15N resonance to the 13CO of the 
preceding residue via inter-residue two bond 15N-13CJ-coupling (2JNC). 
Thus for each NH group, two carbonyl groups are observed in the 
spectrum. Because the 1JNC is stronger than 2JNC, the peak 
corresponding to 13CO of residue i is more intense than the peak with the 
13CO frequency of the preceding residue. A disadvantage of the 
HNCA/HN(CO)CA and HNCO/HN(CA)CO pairs is the small chemical 
shift dispersion of the 13C and the 13CO spins, which can cause 
significant resonance overlap, leading to ambiguous assignments. To 
obtain additional information, the 13C spin can be used. A combination 
of HNCACB and CBCA(CO)NH experiments, allows to correlate the 
13Cchemical shift with the backbone resonances. In addition, the 
13Cand 13Cchemical shifts provide information on the type of amino 
acid that can also be employed to position sequentially connected 
fragments within the amino acid sequence. The HNCACB experiment 
transfers magnetization from the amide proton via the 15N to the 13Cand 
further to the 13Cspins (107). The resulting spectrum contains the 
correlations between 1HN and 15N of amino acid i and the  and 
carbons of amino acids i and i–1 (Figure 2.11). 
The CBCA(CO)NH experiment (108) correlates both the 13C and 
13Cresonances of an residue with the 1HN, 15N chemical shifts of the 
following residue. As well as the HN(CO)CA experiment, inter-residue 
correlations are established by transferring coherence via the intervening 
13CO spins. The CBCA(CO)NH spectrum, therefore, contains the same 
information of HN(CO)CA but with the addition of the 13C chemical 
shifts. In figure 2.11 are shown the correlations observed in the 
HNCACB/CBCA(CO)NH spectra.  
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. ) The combination of HNCACB (left spectrum) and CBCA(CO)NH (right 
spectrum) allows to distinguish sequential (i-1) and intra-residual (i) peaks. Moreover in 
the HNCACB it is possible to distinguish between Cand Cbecause of their positive 
(red) or negative (green) signals. 
 
)#) #/!"+
The NMR experiments used for the side chain resonances assignment are 
experiments that correlate the side chain resonances with the already 
known resonances of backbone nuclei (15N, 13Cand13C 
The first step in the side chain assignment is the identification of alpha 
and beta proton resonances (1H and 1Hrespectively). An experiment 
that provides connectivity to 1Hand 1H is the HBHA(CO)NH (109), 
which correlate the 1H and 1H resonances of amino acid i–1 with the 
backbone amide nitrogen and amide proton of amino acid i. The 
magnetization is transferred from 1H to 13C and from 1H to 13C, 
respectively, and then from 13C to 13C. From here it is transferred first 
to 13CO, then to 15N of following residue and finally to 1HN for detection. 
In the resulting three dimensional spectrum it is possible to identify, per 
each amide group (with known backbone assignment), the resonances of 
1H and 1H of the preceding amino acid.  
From knowledge of 13C, 13C, 1Hand 1H resonances it is then 
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possible to complete the side chain assignment. The full assignment is 
achieved by combining two 3D double-resonance experiments, the 
(H)CCH-TOCSY and H(C)CH-TOCSY (110, 111). These experiments are 
used to assign aliphatic 1H,13C spin systems within residues, and to link 
them to the sequentially assigned backbone resonances. The (H)CCH-
TOCSY spectrum correlates an aliphatic 13C-1H pair with all 13C nuclei of 
the same side chain. In the spectrum two of the three dimensions 
correspond to 13C and the other one to 1H. Starting from a spin system 
with 13C and 1H(or 13C and 1H) resonances assigned, it is feasible to 
identify the chemical shifts of all aliphatic 13C belonging to that side 
chain. The related H(C)CH-TOCSY experiment correlates an aliphatic 
13C-1H pair with all aliphatic 1H nuclei of the same side chain. The 
H(C)CH-TOCSY spectrum, in which two of the three dimensions 
correspond to protons and the third one to carbon, is used in the 
assignment of all aliphatic 1H nuclei. In figure 2.12 is reported a 
schematic example of correlations observable in the (H)CCH-TOCSY (A) 
and H(C)CH-TOCSY (B) spectra. 
 
.)The combination of (H)CCH-TOCSY (left spectrum) and H(C)CH-TOCSY 
(right spectrum) allows to identify all side-chain resonances. In figure is shown an 
example of strips observable for a valine residue. From the knowledge of 13C, 13C, 
1H and 1H chemical shifts, it is possible to assign the resonances of 13Cand 13C in 
the (H)CCH-TOCSY and the resonances of methyl protons 1H1 and 1H in the 
H(C)CH-TOCSY.  
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Once the sequential assignment is complete, the secondary structure of 
the protein can be determined from the secondary-structure specific 
chemical shifts. A commonly utilized method is the CSI protocol (112). 
The CSI method relies on the C, C, CO and 1H shifts. The protocol 
uses a two-step digital filtering process. In the first step, a chemical-shift 
index (CSI) of -1 or 0 or +1 is assigned to each residue based on the 
chemical shift of a particular nucleus relative to an appropriate random-
coil value. In the second step, secondary structural elements are identified 
by a clustering of identical chemical-shift indices. With this CSI protocol, 
helices are indicated by a cluster of chemical-shift indices having value 
+1 for C and CO, and -1 for 1H. In contrast, -strands are indicated by 
a cluster of chemical-shift indices having value -1 for C and CO, and +1 
for 1H and C. An example of CSI output is shown in figure 2.13. 
 
. )# Histogram representation of the chemical-shift index obtained for 1H 
proton of an / protein. Arrows represent -strands and coils represent -helices.  
 
The experimental chemical shift of 13C, 13C 13CO, 15N, 1HN and 
1Hcan be also used for backbone dihedral angles determination by 
TALOS+ (113). TALOS+ compares the similarity in amino acid sequence 
(residue triplets) and chemical shifts of the protein under study with 
proteins of known structure in its database in order to make quantitative 
predictions for the protein backbone angles phi and psi. The structural 
information contained in dihedral angles can be subsequently used in the 
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protein structure calculation. Moreover the experimental chemical shifts 
can also be used as input for a structure prediction using CS-ROSETTA 
software (114). CS-Rosetta protocol matches the experimental chemical 
shifts of the backbone to a structural database to identify protein 
fragments with similar chemical shifts. Selected protein fragments are 
then used as input for a fragment assembly procedure to make a reliable 
prediction of the 3D structure. The output models are then re-evaluated by 
adding a chemical shift term to the all atom energy score. The chemical 
shift term is basically a term that compares the original chemical shifts 
with the back-calculated chemical shifts of a generated model (using 
SPARTA). Finally, the "new" lowest energy model is compared to the 
other generated models (Figure 2.14). If the difference between the 
models (evaluated by RMSD on Cand the all atom score shows 
convergence, the lowest energy model is deemed successful and accepted. 
 
.)$ Plot of rescored Cs-Rosetta all-atom energy against C RMSD relative to 
the lowest-energy model. The convergence for this model shows a “funneling 
distribution”, suggesting that the CS-Rosettastructure generation process has converged. 
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The determination of three-dimensional protein structures in the solution 
state by NMR spectroscopy relies largely upon the measurement and 
interpretation of a large number of Nuclear Overhauser Effect (NOE) 
interactions between the neighbouring protons. The NOE originates from 
cross-relaxation between dipolarly coupled spins. The intensity of an 
NOE is related to the distance r between the two interacting spins as 1/ r6. 
Thus, from the NOE intensities, it is possible to derivate distances 
restraints, which are used as input for the structure calculation.  
After the assignment of all or nearly all resonances of a protein, 3D 13C- 
and 15N- NOESY-HSQC spectra are generally used to obtain the NOEs 
structural information. The NOESY-HSQC pulse sequence basically 
consists of an homonuclear 2D NOESY pulse sequence followed by a 1H-
X HSQC pulse sequence (where X=13C or 15N heteronucleus). The 2D 
NOESY (Nuclear Overhauser Effect SpectroscopY) experiment is based 
on the same principles of the homonuclear 2D experiments, while a 2D 
HSQC (Heteronuclear Single Quantum Correlation) pulse sequence starts 
with the proton magnetization and ends up with proton detection. In the 
first part of the sequence the proton magnetization is transferred with an 
appropriate pulse sequence via 1JXH to the heteronucleus that evolves 
during the t1 period. In this way, the proton spin is labelled with a 
modulation arising from the heteronucleus. After the time t1 the 
magnetization is transferred back to the proton and detected during t2. 
In the combined 3D 15N-NOESY-HSQC (115-117) NOE connectivities 
between the backbone amide protons (1HN) and the spatially neighboring 
protons are observed. In particular the experiment allows the detection of 
protons, either within the same or in other residues, that are closer than 5 
Å. In this experiment, the magnetization is exchanged between all 1H 
using the NOE (2D homonuclear NOESY experiment) and then is 
transferred to 15N, via 1JNH, and finally back to 1HN for detection (1H-15N 
HSQC experiment) (Figure 2.15). The 15N NOESY-HSQC spectrum can 
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provide information that can be used also in the assignment procedure to 
identify the sequential neighbor.  
 
.)%Schematic illustration of correlations observed in a 3D NOESY-HSQC. The 
mechanism involves 1H-1H NOE step followed by an heteronuclear transfer via 1JXH. 
 
Characteristic sequential NOEs, which are, however, secondary-structure 
dependent (100), can be observed in the 3D NOESY-HSQC spectra 
(Figure 2.16). For -helices, sequential amide protons are in close 
contact, giving rise to amide-amide (1HN-1HN) NOEs. On the other hand, 
in -sheets, very strong NOEs between the amide protons and the 1H of 
preceding residue (1HN(i)-1H(i-1)) are generally observed. 
The 3D 13C-NOESY-HSQC (115-117) provides NOE correlations 
between an aliphatic 13C-1H pair and all protons with an internuclear 
distance of less 5 Å. Similarly to the 3D 15N-NOESY-HSQC experiment, 
the mechanism involves an initial step where the magnetization is 
exchanged between all hydrogens using the NOE and a second step in 
which the magnetization is transferred to the heteronucleus via 1JCH. To 
observe the NOEs between an aromatic 13C-1H pair and all protons that 
are close in space, it is necessary to record a second 3D 13C-NOESY-
HSQC, optimizing the 13C frequency offset and the value of the1H-13C 
couplings used during the pulse sequence.  
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.)0The 15N-NOESY-HSQC provides the NOEs correlation between an amide 
proton and all 1H which are within of 5Å of the 1HN. The strips show the observable 
NOEs for sequential amide groups. The lines indicate the observable 1HN-1HN and1HN(i)-
1H(i-1) correlations. 
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Knowledge about the binding site and the distances of nuclei of two 
binders is necessary to obtain an high resolution structure of a complex. 
Several NMR approaches can be used for the identification of protein and 
ligand atoms involved in the interaction and their intermolecular 
distances.  
In my thesis work, the NMR approaches used to collect inter-molecular 
information can be divided into two classes, depending on whether i) 
protein resonances or ii) both protein and ligand resonances are observed. 
i. The observation of protein-ligand binding relies on the detection of 
chemical shift changes of protein resonances upon titration of the 
protein with increasing amounts of ligand and it is called chemical 
shift perturbation (CSP). If a ligand containing a paramagnetic ion is 
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employed, broadening of protein signals can provide information on 
intermolecular restraints. Indeed protons located 15 to 20 Å away 
from the paramagnetic ion can experience an increase in their 
relaxation rates. This effect is called paramagnetic relaxation 
enhancement (PRE). 
ii. This second approach relies on the observation of intermolecular 
cross-relaxation effects between the protein and the ligand. The 
identification of intermolecular NOEs requires the assignment of 
both protein and ligand resonances and provides the most important 
information for the structure determination. 
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The most used NMR method for studying protein-ligand interactions is 
based on chemical shift changes resulting from complex formation. The 
HSQC experiments allow the detection of ligand binding over a wide 
range of KD values. The HSQC spectra can be performed on a 15N or on a 
13C labelled protein. In the first case, the 1H-15N HSQC is an experiment 
designed to correlate proton chemical shifts with the chemical shifts of 
the 15N atoms to which they are attached. In the resulting NMR spectrum, 
each signal corresponds to an amide group (NH group) of each amino 
acid residue. Thus a 1H-15N HSQC spectrum is like a “fingerprinting” of a 
protein, where the number of peaks in the spectrum is indeed close to the 
number of residues in the protein (NH groups of the backbone plus NH2 
groups of the side chains, such as Asparagine and Glutamine, and protons 
attached to nitrogen of aromatic residues such as Tryptophan and 
Histidine).  
The binding-induced shift can derive from two distinct phenomena: 
 upon ligand addition chemical shifts of the protein residues at the 
binding interface will be perturbed by the proximity of the partner; 
 the addition of the ligand may induce structural rearrangement in the 
protein, even at distant sites. 
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Thus the analysis of the shift changes can give information on the binding 
interface and on the conformational changes of the protein, even though it 
not always possible to disentangle the two effects. The identification of 
residues involved only in the binding interface, can be better achieved 
through a 1H-13C HSQC titration experiment, as 13Cshift changes 
should be less sensitive to conformational changes with respect to NH 
signals. 
The protein binding site can also be easily identified when the ligand 
contains a paramagnetic metal ion. Indeed the presence of unpaired 
electrons on the paramagnetic centre greatly affects longitudinal and 
transverse relaxation rates (R1 and R2 respectively) of neighbouring nuclei 
due to spin-electron dipolar interactions. Thus NMR lines become broader 
on decreasing the distance between the metal and the observed nucleus. 
The comparison of 2D 1H-15N HSQC spectra of the 15N labelled protein 
in the absence and in presence of the ligand bearing the paramagnetic ion, 
allows the quantification of intensity changes of affected resonances. As 
relaxation rate enhancement effects depend on the metal-to nucleus 
distance, it is possible to calculate such distance according to the 
following equation: 
              R1,2 = f Kdip / r6                                  (2.6) 
where R1,2  is the difference in relaxation rates measured in the absence 
and in presence of the paramagnetic ligand, f is the occupancy factor of 
the binding site and Kdip is the sum of the Salomon and Curie constants 
(118) and depends on operating frequencies, on the electronic relaxation 
times of the metal ion, on the lifetime of the protein-ligand adduct and on 
the overall rotational correlation. Once an estimate of the proportionality 
constant is given the metal-nucleus distances can be obtained. 
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Assignment of the 1H resonances of unlabelled small ligand when bound 
to a macromolecule cannot be performed in a simple 2D homonuclear 
NOESY experiment due to the presence of a large number of cross peaks 
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resulting from the dipole-dipole interaction of both protein and ligand 
protons. The use of isotope-filtered experiments in combination with 
appropriate labelling strategies, allows distinguishing intramolecular 
NOEs within the bound ligand or protein and protein-ligand 
intermolecular NOEs. It is often more straightforward and cost-effective 
incorporate isotope labels into the protein than into the ligand. Thus, in 
the example of a binary complex consisting of a 15N13C-labelled protein 
and an unlabelled molecule (ligand), three kinds of NOE cross peaks can 
be observed (Figure 2.17):  
 intramolecular NOEs of protein (1H-(13C; 15N)  1H-(13C; 15N)); 
 intramolecular NOEs of ligand (1H-(12C; 14N) 1H-(12C; 14N)); 
 intermolecular NOEs between protein and ligand (1H-(13C; 15N) 1H-(12C; 14N)) 
 

. )1 Scheme of the intramolecular and intermolecular NOEs that can be 
observed in a complex between a labelled protein and unlabelled ligand. 
 
The connectivity of protons to the heteronuclei 13C and 15N can be used to 
separate intra- and intermolecular NOEs of protein and ligand. Two 
different experiments are used:  that remove 
coherences of heteronucleus-bound protons and detect only 1H signals 
attached to 12C and 14N nuclei;  &'
 that select the magnetization of 1H bound to 13C and 15N 
heteronuclei and remove the ligand signals, i.e. the 1H signals attached to 
12C and 14N nuclei. Examples of isotope-edited experiments are the 3D 
NOESY-HSQC, in which the magnetization of 1H bound to heteronucleus 
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is selected to detect intramolecular protein NOEs. 
In order to identify only the signals of unlabelled ligand, two different 
experimental strategies have been proposed for filtering. The original idea 
behind filtering methods comes from Ernst and co-workers, who 
introduced the concept of purge filter (or low-pass J filter) to allow the 
suppression of coherences of heteronucleus-attached protons on the basis 
of J-coupling evolution (119). A second method, originally developed by 
Wuthrich and co-workers (120, 121) makes use of a spin echo difference 
scheme, whereby 1H-13C or 1H-15N pairs are selected against on the basis 
of the difference in sign of magnetization originating from protons that 
either are or are not one-bond coupled to 13C or 15N spins. In figure 2.18 
is reported the pulse scheme of isotope filtering with a low pass J filter 
element that rejects the magnetization of protons attached to the 
heteronucleus. 
 
.)2 Pulse sequences with purge filter elements. A) basic low pass J filter with 
90°(X) purge pulse. For optimal performance the delay is set to 1/2JHX. B) composite 
purge filter produced by concatenation of two purge filter elements. 
 
The pulse sequence starts with a 90° proton pulse followed by a delay 
optimized on the one bond H-X J-coupling constant (1/(21JHX)). During 
this delay, the proton magnetization (coupled to the heteronucleus) 
acquires an anti-phase character with respect to its directly attached 13C or 
15N spin. At this point a 90° purge pulse on the heteronucleus X converts 
the anti-phase term (H-{X}) into multiple quantum magnetization that is 
unobservable, while leaving the in-phase magnetization of the non-X-
bound protons unaffected. The 180° pulse on the protons refocuses the 
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proton chemical shift evolution that occurs during the delay. To achieve 
better suppression of anti-phase magnetization that escapes conversion to 
heteronuclear multiple quantum magnetization (as a result of pulse 
imperfections), the phase  of the X-nucleus 90° pulse is cycled x, -x. To 
improve the level of suppression, a second purge can be applied after a 
further 1/(21JHX) delay. The resulting composite filter is more tolerant to 
slight variation in J-couplings. This is especially useful for the acquisition 
of 13C-filtered 1H spectra where there is a spread of 1JHC value 
(1JHCali=120-145 Hz, 1JHCaro=160-220Hz). In this concatenation approach, 
the two purge filter elements can be tuned for different values of 1JHC and 
thus much more efficient suppression can be achieved over a wider range 
of 1JHC. 
In the past several different implementations of this approach have been 
proposed (122). In this thesis, we performed doubly-filtered [F1-C/N, F2-
C/N] NOESY experiments (123) with heteronuclear filter acting in both 
F1 and F2 for observation of exclusively intramolecular distances within 
the unlabelled bound ligand, The doubly-filtered [F1-C/N,F2-C/N] 
NOESY uses the low-pass J-filter principle, and permits to remove 
simultaneously the coherence of 15N- and 13C-bound protons by 
converting it to undetectable multiple-quantum coherence. Moreover the 
uniform suppression of proton resonances attached to the 13C 
heteronucleus is achieved optimizing the suppression of aliphatic 
resonances in the F1 dimension and aromatic resonances in the F2 
dimension. In this experiment the NOEs originating from the 15N13C-
labelled protein are filtered out in both dimensions and thus the resulting 
spectrum contains only the intramolecular NOEs of ligand (1H-(12C; 14N) 
1H-(12C; 14N)). In figure 2.19 is reported a comparison between a 2D 
NOESY experiment recorded without any filtering and with [F1-C/N, F2-
C/N] filtering. 
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.)3 Observable peaks in a 2D NOESY experiment (left) and in doubly-filtered 
[F1-C/N, F2-C/N] NOESY experiment (right). In the 2D NOESY spectrum 
intramolecular NOEs of the protein (red circles), intramolecular NOEs of the ligand 
(blue circles) and intermolecular NOEs between protein and ligand (pink circles) are 
schematically drawn. In the doubly-filtered NOESY experiment all 1H signals attached 
to 13C15N nuclei are rejected and thus only the intramolecular NOEs of ligand are observed. 
 
A drawback of this experiment is that signals belonging to the free ligand 
can be observed in the spectrum. The result is that a more crowded 
spectrum is obtained and the assignment of bound-ligand resonances 
becomes more complicated. An approach to detect only proton signals of 
the unlabelled ligand experiencing NOEs with labelled protein (bound 
ligand protons) is the acquisition of filtered isotope experiments for 
observing intermolecular NOEs (next section). 
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In order to observe only intermolecular NOEs between the labelled 
protein and an unlabelled bound ligand, isotope-filtering has to be applied 
in the one dimension, and a isotope-editing in the other dimension (Figure 
2.20). In the dimension where filtering is applied are detected only proton 
signals from unlabeled protons, while in the dimension where editing is 
applied the only proton signals that are directly detected are from labelled 
protons. Thus, the resulting spectrum contains only the intermolecular 
NOEs between labelled protein and unlabelled ligand (1H-(13C; 15N) 
1H-(12C; 14N)).  
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.)5 Observable peaks before and after the application of an isotope-filter in one 
dimension (in this example F1) and an isotope-editing in the other dimension (F2). The 
peaks are coloured as reported in the previous figure. In F1 the 1H signals attached to 
13C15N nuclei are removed (observable only 1H signals of ligand), while in F2 are select 
the signal of labelled protein and the 1H signals of ligand are removed. Thus the resulting 
spectrum will show only the intermolecular NOEs between protein and ligand. 
 
In a simple 2D experiment the unambiguous assignment of protein 
protons is difficult due to high overlap, thus it is often beneficial to 
conduct the isotope-editing as a multidimensional experiment (and in this 
case it is referred as isotope-separation), exploiting the chemical shift 
dispersion of the heteronucleus to increase the spectral resolution for the 
labelled protein. This can be done using hybrid schemes combining purge 
filters for selecting non-X bound proton signals in one proton dimension 
with sequences for recording 3D isotope-separated NOESY spectra.  
The identification of intermolecular NOEs in this study has been 
performed recording a 3D F1-[13C]-filtered,F2-[13C]-separated,F3-[13C]-
edited NOESY-HSQC spectrum in D2O. The pulse sequences of the 
experiment select for magnetization transferred from protons on the 
unlabelled component to proximal protons of the labelled molecule. 
Differently from 2D double filtered NOESY used to observe 
intramolecular NOEs of ligand, in this experiment the purge filter element 
is a WURST pulse (124) (Figure 2.21). 
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.)WURST-based purge filter element. 
 
In this filter element the conventional 13C inversion pulse is replaced by a 
pulse whose frequency is swept adiabatically during the filter delay, such 
that inversion of carbon magnetization is inverted at different times for 
carbon of different chemical shift. During this period (2) the desired 
magnetization from protons not scalarly coupled to 13C is stored along the 
z-axis. At the end of the 2 period the gradient g2 dephases the antiphase 
magnetization arising from 13C-bound protons and thus only the protons 
attached to 12C evolve during t1. The filtered magnetization is then 
subjected to a NOESY pulse sequence, followed by an HSQC sequence, 
which is used to correlate the protons which are “excited” by the NOESY 
mixing to 13C through their 1H-13C scalar couplings. After the chemical 
shift evolution of 13C in t2, the protons directly attached to it are detected.  
In F1 dimension of the resulting experiment only the signals of the 
unlabelled ligand protons are observable, while in the other two 
dimensions only the proton (F3) and carbon (F2) signals of the labelled 
protein are observable.  
 
As underlined in the previous section (2.5.2), filtered experiments that 
combine filter and isotope elements can also be used to detect only the 
signals of bound ligand. 
Only resonances of protons bound to 12C and exhibiting NOE with protein 
can be observed in the Fourier-transformed first fid of several 
experiments F1-edited, F3-filtered 3D HMQC-NOESY recorded with 
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different mixing-time (125). Differently from 3D F1-filtered, F2-separated, 
F3-edited NOESY-HSQC, the sequence of 3D F1-edited, F3-filtered 
HMQC-NOESY experiment starts with a heteronuclear multiple quantum 
coherences block (in which are observable the correlations between 
directly-bonded 1H and X-heteronuclei) and the succeeding 1H-1H NOE 
mixing time is followed by a 13C double purging filter. During the mixing 
time, the magnetization is transferred between dipolarly coupled spins and 
only those NOEs corresponding to the transfer of magnetization from 13C-
bound protons to 12C-bound protons are selected during the subsequent 
purging scheme. By recording spectra incrementing the mixing time 
period, it is possible to observe the growth of NOEs signals resulting from 
intermolecular interaction. The superimposition of different transformed 
first fid allows establishing the assignment of protons ligand (Figure 2.22). 
 
.)Fourier transformed first fid of different 3D F1-edited, F3-filtered HMQC-
NOESY experiments recorded increasing the mixing time. In this superimposition the 
growth of the proton signals of ligand that exhibited NOEs only with the protein is 
observable. In black the experiment (reference spectrum) recorded with mixing time zero.  
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At this stage, once established the assignment of some proton resonances 
of the ligand and 13C-1H pairs of almost all the labelled protein, it is 
possible to assign the intermolecular NOEs observed in the 3D F1-filtered, 
F2-separated, F3-edited NOESY-HSQC spectra and obtain the restraints 
needed for the structural determination of protein-ligands complex. 

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In de novo 3D structure determinations of proteins in solution by NMR 
spectroscopy, the key conformational data are upper distance limits 
derived from NOEs. In order to extract distance constraints from a 
NOESY spectrum, its cross peaks have to be assigned, that is, the pairs of 
interacting atoms that give rise to the observed cross peak have to be 
identified. Because of the limited accuracy of chemical shift values and 
signals overlap, many NOESY cross peaks cannot be attributed 
unambiguously to a single unique spin pair. In addition to the problem of 
resonance and peak position, considerable difficulties may arise from 
spectral artefacts, noise and from the absence of expected signals because 
of fast relaxation or conformational exchange. In principle it is possible to 
solve such ambiguities during the structure calculation process using an 
automatic interactive procedure. Several structure calculation softwares 
have been supplemented with the automated NOESY assignment routine. 
In my thesis work the structure calculation has been performed using the 
program CYANA (126), which contains the CANDID (127) algorithm for 
automated NOE assignment. Figure 2.23 reports a general scheme 
showing the iterative approach of automated combined NOESY 
assignment and structure calculation used in the CYANA software.  
 




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. )# General scheme of an automated combined NOESY assignment and 
structure calculation. 
 
The automated CANDID method proceeds in iterative cycles (seven 
cycles), each consisting of ambiguous NOE assignment followed by a 
structure calculation with the CYANA torsion angle dynamics algorithm. 
Between subsequent cycles, information is transferred exclusively 
through the intermediary 3D structures, so that the protein molecular 
structure obtained in a given cycle is used to guide further NOE 
assignments in the following cycle. Otherwise, the same input data are 
used for all cycles, i.e. the amino acid sequence of the protein, a complete 
chemical shift assignment list and one or several lists containing the 
positions and volumes of cross peaks collected in 3D dimensional 
NOESY spectra. 
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A CANDID cycle starts by generating for each NOESY cross peak an 
initial assignment list from the fit of chemical shift values with the peak 
positions, using a user-defined tolerance range. Subsequently, for each 
cross peak these initial assignments are weighted with respect to several 
criteria and initial assignments with low overall score are then discarded. 
The filtering criteria include the agreement between the values of the 
chemical shift list and the peak position, the presence of symmetry-related 
cross peaks, the compatibility with covalent polypeptide structure and, 
most importantly, element, the self-consistency within the entire NOE 
network. The second and subsequent cycles differ from the first cycle in 
the use of additional selection criteria for cross peaks and NOE 
assignments that are based on assessments relative to the protein three-
dimensional structure from the preceding cycle. For each cross peak, the 
retained assignments are interpreted in the form of an upper distance limit 
derived from the cross peak volume. In order to reduce deleterious effects 
on the resulting structure from erroneous distance constraints that may 
pass this filtering step, long-range distance constraints are incorporated 
into “combined distance constraints”. The distance constraints are then 
included in the input for the structure calculation with the CYANA torsion 
angle dynamics algorithm. In the first cycle, network anchoring and 
constraints combination have a dominant impact for the successful 
generation of the correct polypeptide fold, since structure-based criteria 
cannot be applied yet. Network-anchoring exploits the observation that 
the correctly assigned constraints form a self-consistent subset in any 
network of distance constraints is sufficiently dense for the determination 
of a protein three-dimensional structure. Network-anchoring thus 
evaluates the self-consistency of NOE assignments independently of 
knowledge of the three dimensional protein structure. 
Constraint combination consists of generating virtual distance constraints 
with combined assignments from different, generally unrelated, cross 
peaks. The basic property of ambiguous distance constraints, namely that 
the constraints will be fulfilled by the correct structure whenever at least 
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one of its assignments is correct, regardless of the presence of additional 
erroneous assignments, implies that such combined constraints have a 
lower probability of being erroneous with respect to the corresponding 
original constraints. In the final CANDID cycle (cycle 7), an additional 
filtering step ensures that all NOEs have either unique assignments to a 
single pair of hydrogen atoms, or are eliminated from the input for the 
structure calculation.  
Each CANDID cycle is completed by a structure calculation using the 
CYANA torsion angle dynamics algorithm, which uses as input the list of 
distance constraints from CANDID and possibly additional 
conformational constrains such as dihedral angle constraints. 
In the program CYANA, the structure calculation is based on molecular 
dynamic simulated annealing (SA) protocol performed in torsion angle 
space. A general feature of this protocol is that it uses a “target function” 
that measures how well the calculated structure fits the experimental data 
and the chemical information; the lower this function, the better the 
agreement. The chemical information is defined in the force field that 
contains terms such as bond length, bond angles, van der Waals 
interactions. Therefore, the calculation of the 3D structure is formulated 
in CYANA as a minimization problem for a target function that measures 
the agreement between a structure and the given set of constraints. 
The minimization algorithm in CYANA is based on simulated annealing 
by molecular dynamic simulation in torsion angle space. Torsion angle 
dynamics consists in molecular dynamic simulation using only torsion 
angles as degree of freedom. The degree of freedom of torsion angles 
dynamics is the rotation about covalent bonds, so the number of degrees 
of freedom is reduced respect to the Cartesian coordinates. Compared to 
the minimization of a target function, the molecular dynamics simulation 
comprises also the kinetic energy that allows overcoming barriers of 
potential, reducing the probability of encountering a local minimum.  
The potential energy landscape of a protein is complex and studded with 
many local minima. Because the temperature, i.e. the kinetic energy, 
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determines the maximal height of energy barriers that can be overcome in 
a molecular dynamics simulation, the temperature schedule is important 
for the success and efficiency of a simulated annealing calculation. The 
standard simulated annealing protocol in CYANA starts from a 
conformation with all torsion angles treated as independent and consists 
of five stages. An initial minimization step, including initially only 
distance constraints between atoms up to 3 residues apart along the 
sequence, is carried out in order to reduce high-energy interactions that 
could disturb the torsion angle dynamics algorithm. In the second stage 
(high-temperature phase) a torsion angle dynamics calculation at constant 
high temperature is performed, then followed by torsion angle dynamics 
calculation with slow cooling to temperature close to zero. Up to this 
point the hydrogen atoms have not been included in the calculation. They 
are included in this fourth stage of low temperature phase to check for 
steric overlap. The final stage consists of a minimization of 1000 
conjugate gradient steps. With the CYANA torsion angle dynamics 
algorithm it is possible to efficiently calculate protein structures on the 
basis of NMR data.  
The structures of proteins calculated in this thesis work were obtained 
using the standard torsion angle dynamics simulated annealing protocol. 
Hundred trial structures were generated in each cycle and the 20 
structures with the lowest target function values were chosen to represent 
the solution structure. The correctness of the resulting 3D structure has 
been assessed using the CYANA output criteria; these criteria are as 
follow: 
 average target function for cycle 1 below 250 	 
 average target function for cycle 7 below 10 	 
 less than 20% unassigned NOEs 
 less than 20% discarded long- range NOEs 
 RMSD for cycle 1 below 3	 
 RMSD between cycles 1 and 7 below 3	 
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For the assessment of protein structures quality, two different tools were 
used, the i-CING (128) and the PSVD (129) server. I-CING is part of the 
Common Interface for NMR structure Generation (CING) package and 
integrates the data generated by PROCHECK, WHAT_IF, Wattos, ShiftX. 
The analysis with the i-CING suite provides information on the 
stereochemical quality of the structures as well as their agreement with 
experimental restraints. i-CING is particularly informative on possible 
errors at the “per-residue” level using a very straightforward colouring 
scheme for visualisation of all its assessments (peaks, restraints, residues, 
assignments). This is called ROG coding, where:  
 Red means there is something wrong; 
 Orange means there might be something wrong; 
 Green means it is ok. 
The other validation suite used was PSVS. Also PSVS checks 
stereochemical parameters as well as the agreement with experimental 
data. The latter integrates analyses from several widely used structure 
quality evaluation tools, including PROCHECK, but also RPF, 
MolProbity, Verify3D, Prosa II and the PDB validation software. PSVS 
provides standard constraint analyses, statistics on the PDB validation 
goodness-of-fit between structures and experimental data, and 
knowledge-based structure quality scores in standardized format suitable 
for database integration. Global quality measures are reported as Z scores, 
based on calibration with a set of high-resolution X-ray crystal structures.  
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As stated initially, the docking protocol used to obtain high resolution 
structure of the protein-ligand complex has been performed by 
HADDOCK (High Ambiguity Driven biomolecular DOCKing) approach 
The docking protocol is implemented in CNS (95) for structure 
calculations and makes use of python scripts derived from ARIA for 
automation (130). 
Chapter 2 
72 
 
The docking protocol requires the PDB files of protein and ligands as 
input together with ambiguous and unambiguous distance restraints. The 
starting holo protein structures were the 10 best structures (lowest target 
function) of the final bundle obtained by CYANA calculation. The 
starting coordinates of ligands were obtained with the program SMILE 
(131), while the topology and parameter files were calculated using 
PRODRG server (132). Ambiguous interaction restraints (AIR), that 
provide information on the interaction interface, were derived from NMR 
experiments, such as chemical shift perturbation and filtered experiments. 
In Haddock the protein residues directly affected by ligand interaction are 
defined as “active residues”, while neighbours of active residues are 
defined as “passive residues”. For every active residue, a single AIR is 
defined between that residue and all active and passive residues on the 
binder molecule. The distance of an AIR between any atom m of active 
residue i of the protein A (miA) and any atom n of both active and passive 
residues k (Nres in total) of the molecule B (nkB) (and inversely for 
molecule B) is calculated using the equation: 
 
(2.7)
 
where diABeff is the effective distance between the two molecules A and B, 
Natoms indicates all atoms of a given residue and Nres the sum of active 
and passive residues for a given protein. A 1/r6 sum averaging is used, not 
by analogy to NOE restraints, but because this mimics the attractive part 
of a Lennard-Jones potential and ensures that the AIRs are satisfied as 
soon as any two atoms of the two molecules are in contact. The definition 
of passive residues ensures that residues that are at the interface but are 
not detected by NMR experiments, are still able to satisfy the AIR 
restraints. 
Intermolecular NOE-derived distances obtained from the analysis of 
NMR isotope-filtered experiments were introduced in the docking. Since 
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initially only a small number of assigned intermolecular distance 
restraints can be used, we performed several docking calculations to 
identify and assign new intermolecular NOEs, in order to improve the 
accuracy of final protein-ligand complex structure.  
To solve the structure of the protein in complex with a paramagnetic 
ligand, additional ambiguous and unambiguous restraints can be added. In 
particular, the paramagnetic attenuation of protein amide resonances due 
to the presence of paramagnetic ion are used as AIRs, while 
intermolecular metal-nucleus distances derived by paramagnetic 
relaxation measurement are introduced as unambiguous intermolecular 
restraints to drive the docking.  
To obtain a high resolution structure of the protein-ligand complex with a 
docking approach, additional restraints derived from the holo CYANA 
structure are used as input in order to ensure the consistency with the all 
experimental data, i.e. that the protein structure in the complex satisfies 
the experimentally derived intramolecular distances. Specifically, we used 
dihedral angles restraints derived by TALOS to maintain the secondary 
structure of the protein, and also, as unambiguous distances, all 
intramolecular NOEs distances used to calculate the final ensemble of 
holo protein structure. 
The HADDOCK docking protocol consists of three stages: 
 randomization of orientations and rigid body energy minimization (EM); 
 semi rigid simulated annealing in torsion angle space (TAD-SA); 
 final refinement in Cartesian space with explicit solvent. 
In the randomization stage, the protein and ligands are positioned at 15 Å 
from each other in space and each one is randomly rotated around its 
centre of mass. Rigid body EM is then performed: first, four cycles of 
orientational optimization are performed in which each binder in turn is 
allowed to rotate to minimize the intermolecular energy function. Then 
both translations and rotations are allowed, and the protein-ligand 
molecules are docked by rigid body EM. For each starting structure 
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combination, this step can be repeated a number of times. Generally, a 
large number of complex conformations are calculated in this stage (in the 
order of 1000 to 4000 solutions). The best solutions in terms of 
intermolecular energies are then select for the next step.  
In the second stage, three different simulated annealing are performed, 
during which increasing amounts of flexibility are introduced. That 
permits that the amino acids at the interface (side chains and backbone) 
are allowed to move to optimize the interface packing. In the first 
simulated annealing, the binders are considered as rigid bodies and their 
respective orientation is optimized. In the second simulated annealing 
only the side chains of protein at the interface are allowed to move. In the 
third simulated annealing both side chains and backbone at the interface 
are allowed to move to allow for some conformational rearrangements. 
The resulting structures are then subjected to a minimization steps. 
The final stage consists of a final water refinement in an explicit solvent 
layer (8Å for water). Although no real significant structural changes occur 
during the water refinement stage, the side chains and backbone at the 
interface are free to move. That is useful for the improvement of the 
energetics of the interface.  
The final structures are clustered using the pairwise backbone RMSD at 
the interface and scored using a combination of energy terms (Eelec, Evdw, 
EAIR) and their buried surface area. The final ensemble of protein-ligand 
complex is represented by the best (lowest) HADDOCK score structures 
of the best (lowest) HADDOCK score cluster. 
The structures of protein-ligand complexes calculated in this thesis work 
were obtained using the standard HADDOCK protocol, but defining the 
entire protein as fully flexible. This option allows the use of HADDOCK, 
in combination with a reasonable number of unambiguous interaction 
restraints, for structure calculations of complexes as “classical” NOE-
based structure determination approach. Thus, the final bundle of protein-
ligand complex obtained can be considered as NMR solution structure 
and not as a structural model.  











 #   
	 
6;7    ( 	 (
*(	(<&'=
*8"
	











	




Magnetic resonance imaging (MRI) is rapidly emerging as imaging tool for 
detection and characterization of liver lesions. To increase the imaging 
contrast between normal and abnormal tissue, hepatospecific contrast 
agents (CA) are commonly used. One of the most active areas of contrast 
agent development concerns the design of new 7-specific .
The tissue specific targeting of CAs is based on the understanding of the 
mechanism involved in their cellular uptake and interaction with carriers 
proteins.
Recently we have shown that a bile acid-derived Gadolinium contrast 
agent (Gd-DTPA-conjugated to 5-cholanoic acid and called Gd-1) is 
efficiently internalized in hepatocytes and is able to bind to a liver bile acid 
binding protein (L-BABP) in vitro. In particular the protein is able to bind a 
single ligand molecule of Gd-1 with a low dissociation constant (20 ). The 
result prompted us to study the structural details of the complex with the 
purpose of identifying the features of the interaction that only can help in the 
rational design of new hepatospecific CAs. 
In this study, the NMR solution structure of the complex has been solved 
using the data-driven docking software HADDOCK. This approach allows 
obtaining high resolution structures of protein-ligand complexes starting from 
the structure of the protein and incorporating distance restraints between the 
protein and the ligand obtained experimentally by NMR.  
As L-BABP undergoes a substantial structural rearrangement upon Gd-1 
binding, a significant improvement of the docking approach is achieved if the 
structure of the holo protein is used as starting structure. The first step in the 
structure determination of the holo protein requires the complete assignment of 
all the protein resonances in order to proceed to the identification of 
intramolecular protein distance restraints. The final structure ensemble of L-
BABP was determined using the software CYANA. This ensemble has been 
subsequently used for the docking calculation. To guide the docking we used 
both ambiguous (AIR) and unambiguous intermolecular distances. The AIR 
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were obtained from chemical shift perturbations (CSPs) of protein amide 
resonances upon addition of ligand and from paramagnetic attenuation of amide 
signals due to the presence of Gd ion. Unambiguous interaction restraints were 
further introduced in the docking with the aim of obtaining an accurate 
orientation of the ligand. These restraints include both intermolecular distances 
between the protein and the steroid moiety of the ligand (bile acid) and 
distances between the protein and the metal ion. The identification of 
intermolecular restrains between the protein and the steroid moiety was 
performed analyzing isotope edited/filtered NOESY experiments. Only 14 
intermolecular restraints have been identify unambiguously, due to the 
difficulty of assigning the highly overlapped proton ligand resonances. The 
intermolecular restraints between the protein and the metal ion were calculated 
on the basis of paramagnetic relaxation enhancement of amide proton 
resonances due to the presence of the paramagnetic Gd ion. Indeed, 
paramagnetic ion induces an enhancement of longitudinal relaxation rate of 
protein nuclei, and this effect is distance-dependent.
The HADDOCK structure calculation led to a final ensemble of seven 
structures. In the obtained complex the ligand is bound at the portal region of 
the protein, with the steroid moiety buried inside the hydrophobic cavity and 
the Gd-chelating unit, conjugated to the ring A of the steroid moiety, located 
outside the protein cavity.  
The comparison of L-BABP-Gd-1 complex with the other available 
structures of holo BABPs (in complex with bile acids) underlines some 
important differences: 
 Gd-1 accesses the protein cavity in a reverse orientation with respect to bile 
acids. Indeed the latter are bound with ring A of the steroid moiety buried 
in the protein pocket and the carboxylic tail exposed to the solvent. 
 Conformational differences between the proteins in complex with natural 
or synthetic ligands are mainly observed in the portal region of the protein. 
In conclusion, the solution structure of L-BABP in complex with the bile acids-
derived contrast agent underlines the capability of this protein scaffold to adapt 
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itself to different ligands. In this line, the L-BABP can be considered as a good 
carrier for hepatospecific contrast agents.
The protein ligand interactions observed in the determined structure will 
contribute to the rational design and synthesis of new and more efficient 
hepatospecific contrast agents. 
My contribution to this work consisted in production of the protein samples, in 
the assignment of protein resonances and in the analysis of NMR experiments 
for the detection of intermolecular distances restraints used in the docking 
approach.












Chapter 4: Chicken ileal bile-acid-binding protein: a 
promising target of investigation to understand binding 
cooperativity across the protein family 
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Bile acids, besides their importance in physiological processes, such as 
cholesterol homeostasis and enterohepatic circulation, have been recognized to 
be signaling molecules. Activation of nuclear receptors and cell signaling 
pathways by bile acids alters the expression of numerous genes encoding 
enzyme and proteins involved in the regulation of bile acids, lipids, glucose and 
energy metabolism.  
This work addresses the study and proposes a mechanism of interaction 
between bile acids and chicken ileal bile acid binding protein (chicken I-
BABP). Although several data have been reported addressing the interaction of 
different BABPs with bile acids, the binding mechanism is still poorly 
understood. Indeed BABPs from different species or tissues show high 
sequence and structural homology but they bind bile acid molecules with 
different stoichiometry, selectivity and cooperativity. In order to better 
understand the mechanism of ligand binding of BABPs we additionally 
performed a comparative analysis of binding capabilities of chicken I-BABP 
with homologous proteins. 
The interaction of chicken I-BABP with bile acids has been studied 
through different approaches, including chemical shift perturbation mapping by 
NMR titrations and Isotermal Titration Data (ITC).  
The obtained data show that the chicken I-BABP binds two molecules of 
glycochenodeoxycholic acid (GCDA) inside the internal cavity. In addition, in 
response to ligands binding, the protein undergoes a global structural 
rearrangement. ITC data and NMR experiments independently suggest that the 
interaction of chicken I-BABP with GCDA involves two consecutive binding 
events. In particular, the first binding event promotes a large structural 
rearrangement, possibly related to an allosteric mechanism. Both the used 
approaches pointed to the presence of a singly ligated protein at low 
ligand/protein molar ratios, thus suggesting the absence of binding 
cooperativity. Competition experiments performed on cI-BABP with GCDA 
and GCA (glycocholic acid) show the absence of site-selectivity for one site, 
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while the other binding site displays some selectivity for GCDA. A similar 
analysis performed on a mutant (Q51A) does not affect the ligand-specificity 
for GCDA.
 Comparing the binding features displayed by chicken I-BABP with 
homologous proteins (human I-BABP, rabbit I-BABP, zebrafish I-BABP and 
chicken liver BABP), the following considerations can be made: 
 The binding of two ligand molecules inside the internal cavity appears to 
be a common feature of all homologous BABPs. Chicken I-BABP does not 
display any evidence of additional superficial binding sites as reported for 
the rabbit and zebrafish proteins. 
 In order to assess the binding cooperativity displayed by cI-BABP and 
homologues proteins, we calculated, for each protein, the change of free 
energy of interaction between the two internal binding sites, using reported 
macroscopic binding constants. The obtained values indicate that the 
human protein displays the largest cooperativity, the rabbit and zebrafish 
BABPs have intermediate cooperativity, while the chicken protein has poor 
energetic coupling between sites. 
 The identification of substitutions that can correlate with the trends in 
binding cooperativity is not straightforward and the only available high-
resolution structure of an ileal protein with two bile salts bound inside the 
cavity is that of the zebrafish protein. It is thus clear that more structural 
data are necessary in order to identify the determinants of cooperativity. 
 the site-selectivity displayed by chicken I-BABP show differences 
compared to that reported for human I-BABP. Indeed, human I-BABP has 
been found to exhibit a high degree of ligand site selectivity in its 
interactions with GCA and GCDA, and a mutation of glutamine in position 
51 results in the loss of site preference for both bile acids.
In conclusion, we present the characterization of bile acids interactions with 
chicken I-BABP, aimed at contributing to determine the chemical basis of 
intracellular bile acid transport, by taking advantage of comparative analyses 
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with homologous proteins. The chicken I-BABP can be considered as an 
allosteric system, which is able to establish long-range communication 
networks through a significant conformational rearrangement induced by a first 
binding event, but that does not displays positive binding cooperativity, as 
instead observed for the human protein and its paralogous chicken liver BABPs. 
The observed differences in binding features make chicken I-BABP a suitable 
model for the understanding of cooperativity among BABPs and may provide 
indications about the development of this efficient feature during species 
evolution.
My contribution in this work consisted in production of the protein samples, in 
the assignment of protein resonances and in the analysis of NMR titration 
experiments. 
















Chapter 5: NMR investigation of the structural correlates 
of cooperativity in bile acid binding proteins 
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In this study, we have determined the NMR solution structure of the chicken 
ileal BABP (cI-BABP) in complex with two molecules of 
glycochenodeoxycholic acid (GCDA) using NMR derived data in combination 
with the HADDOCK modeling procedure.  
The extensive overlap of the resonances of the two bound identical ligands 
represents a real challenge for the structure determination of the complex. A 
wide variety of NMR experiments, including doubly filtered and edited-filtered 
schemes were performed to identify the intermolecular restraints for the 
structural determination of the complex. The employed HADDOCK procedure 
allowed to follow an iterative procedure for extracting the necessary 
intermolecular restraints to obtain the complex structure with high accuracy.  
A comparison of the obtained ternary complex with the only available 
ileal BABP structure from zebrafish, shows that the internal ligand (GCDA-II) 
has a very similar orientation in the two proteins, with the major differences 
involving the  external ligand GCDA-I.
A comparative structural analysis coupled to a bioinformatics screening 
extended to the other known members of the I-BABP family allowed us to 
identify a key interaction capable of affecting the binding mechanism, 
introducing a gain of cooperativity, as shown by the analysis of the produced 
mutant.
My contribution to this work consisted in the planning and analysis of the 
experiments, in the structure determination of ternary complex and in 
subsequent comparative analysis of different proteins of the I-BABP family.
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Ileal bile acid binding proteins (I-
BABP) belong to the family of 
intracellular lipid binding 
proteins and play an important 
role in transport and release, 
within the cytoplasm, of bile 
acids, thus controlling bile acid 
homeostasis in the enterohepatic 
circulation. We have previously 
shown that chicken I-BABP forms 
a ternary complex with two bile 
salt molecules and we have 
investigated the thermodynamics 
of binding in comparison with 
other proteins of the family. The 
protein under study, namely 
chicken I-BABP, represents a 
suitable model for the mechanistic 
investigation of cooperativy as it 
contains a protein scaffold which 
is able to establish a long-range 
communication network, as 
reflected by the significant 
conformational rearrangement 
induced by the first binding event. 
This behavior indicates that the 
protein behaves as an allosteric 
system, which, however, does not 
display binding cooperativity. The 
question addressed by the present 
work relates to whether we are 
capable of introducing mutations 
that lead to the gain of a function, 
namely cooperativity. Thus NMR 
derived data together with 
HADDOCK were employed to 
initially derive the structure of 
the ternary complex with the aim 
of correlating structural features 
with the level of cooperativity 
exhibited by different proteins of 
the family. This extensive analysis 
allowed us to single out a key 
interaction capable of affecting 
the binding mechanism. 
Intracellular bile acid binding 
proteins (BABP) belong to the fatty 
acid binding protein (FABP) family 
that is composed of abundantly 
expressed small-molecular-mass 
(14-15 KDa) -barrel proteins, 
presumably acting as lipid 
chaperones (1-3). Specifically, 
BABPs were shown to play a 
pivotal role in the transcellular 
trafficking and enterohepatic 
circulation of bile salts (4).  
During the last decade a growing 
amount of evidence has been 
presented that the various 
intracellular lipid binding proteins 
(iLBPs) interacting with lipids not 
only facilitate their transport in 
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aqueous media but, by interacting 
with specific targets, also modulate 
their subsequent biological action or 
metabolism. Therefore, the notion 
arises that for better understanding 
the action of lipids as signalling 
compounds and the role of lipids in 
intermediary metabolism, it is 
essential to have detailed 
knowledge on the interactions 
between lipids and their cognate 
binding proteins (5).  
The binding capability and mainly 
the binding mechanism of these 
proteins appear difficult to be 
captured, in spite of many attempts 
in this direction (6-9). It has been 
definitively ascertained that the 
proteins of the family can form at 
least ternary complexes with their 
putative binders, with two ligand 
molecules located inside the protein 
cavity (10). In few cases, namely 
for zebrafish (11) and rabbit ileal 
BABPs (12), a higher binding 
stoichiometry was detected by X-
ray crystallography and mass 
spectrometry, respectively, with one 
or two additional ligands located on 
the protein surface. However, the 
most intriguing feature identified 
for some members of the family 
relates to macroscopic functional 
characteristics, such as 
cooperativity and site-selectivity 
(8). Human ileal BABP and chicken 
liver BABP, the two most widely 
studied members of the family, 
were shown to display an 
extraordinary degree of positive 
cooperativity, translated, for 
example, in a Hill coefficient close 
to 2 (13). Cooperativity and 
allostery are two closely related 
phenomena, but the exact 
biophysical characterization of 
allosteric communication remains in 
most cases a major challenge. This 
is particularly true for the protein 
family under study, also due to the 
lack of extensive structural 
characterization. Indeed within the 
ileal protein subfamily (I-BABP), 
which appears as a well-separated 
group from our phylogenetic 
analysis, only the structure of holo 
zebrafish with two cholate 
molecules located in the internal 
cavity is known. Data relative to the 
binding stoichiometry and 
thermodynamics were reported for 
the rabbit ileal protein (12). As far 
as the human form is concerned, hI-
BABP, the reported holo structure 
(hI-BABP/GCA) (14) is bound to a 
single ligand, as it was obtained at 
temperatures where one of the two 
ligands could not be observed due 
to exchange broadening of the 
NMR signals. Later NMR and 
calorimetric studies performed on 
hI-BABP and on a series of 
mutants, for the first time addressed 
the issue of possible communication 
pathways between the two binding 
sites(9). However this analysis was 
hampered by the lack of the three-
dimensional structure of the ternary 
complex. Along this line of 
investigation, we have reported an 
interaction study on another 
member of the I-BABP family, 
chicken I-BABP (cI-BABP), with 
the aim of enlarging the knowledge 
on this family and derive 
information on the binding 
mechanism (15,16). This protein 
revealed itself a very good model 
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for this kind of studies. Indeed ITC 
data, supported by NMR titration 
experiments, allowed establishing a 
thermodynamic binding model 
describing two independent 
consecutive binding sites. A singly 
bound protein was found to be 
relatively abundant at low 
protein/ligand ratio thus assessing 
the absence of cooperativity, 
differently from the human protein. 
The measured energetics of binding 
and the analysis of chemical shift 
perturbations suggested that the first 
binding event was capable of 
triggering a global structural 
rearrangement. Consistent with this 
finding, also the enthalpic and 
entropic contributions associated 
with the binding of the first ligand 
indicated an increased stability and 
order of the bound protein. In line 
with the classical definition of 
allostery, implying that the entire 
molecule can undergo a 
conformational transition even 
when it is only partially ligated 
(17), we concluded that I-BABP 
behaves as an allosteric system that 
does not display positive 
cooperativity. Thus it represents a 
suitable and attracting model to 
investigate the molecular basis for a 
gain-of-function on going from non-
mammalian to mammalian species. 
To this aim we first address here the 
3D NMR structural determination 
of cI-BABP in complex with two 
glycochenodeoxycholate (GCDA) 
molecules. This is a challenging 
NMR structural determination due 
to the extensive overlap of the 
resonances of the two identical 
ligands in the complex. In this 
contest we exploited the potentiality 
of the HADDOCK approach (18), 
allowing for an iterative procedure 
for extracting an increasing number 
of intermolecular restraints, to 
derive the 3D structure of the 
ternary complex. A comparative 
structural analysis coupled to a 
bioinformatics screening extended 
to the other known members of the 
I-BABP family allowed us to 
identify a key interaction capable of 
affecting the binding mechanism, 
introducing a gain of cooperativity, 
as shown by the analysis of the 
produced mutant. 
Experimental procedures 
Sample preparation. The expression 
plasmid for single (A101S) and 
double mutant (A101S/H99Q) was 
obtained from that of wild-type 
chicken I-BABP using the 
Quickchange mutagenesis kit. The 
presence of the desired mutations 
was confirmed by plasmid 
sequencing. Recombinant wild type 
and mutant I-BABPs were 
expressed as described previously 
using an Escherichia coli-based 
expression vector (16). Uniformly, 
15N13C-labeled protein was 
produced by growth in M9 minimal 
medium with 15N labeled 
ammonium chloride and 13C-labeled 
glucose as the only nitrogen and 
carbon sources, respectively. 
Protein concentrations for sample 
preparation were determined 
spectrophotometrically measuring 
the absorbance at 280 nm. 
Unenriched bile salts (GCA and 
GCDA) were purchased from 
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Sigma-Aldrich. 15N-Glycine 
conjugates of CDA and CA were 
prepared as previously reported 
(15).
NMR Spectroscopy. NMR samples 
were prepared in 30 mM sodium 
phosphate buffer, pH 6.5, 
containing 0.05% NaN3 and 
90%/10% H2O/D2O or 99%D2O. 
NMR spectra were acquired at 25 
°C with an AvanceIII Bruker 
spectrometer, operating at 600.13 
MHz and equipped with a 5 mm 
TCI cryoprobe and Z-field gradient. 
The NMR samples for the structure 
determination contained 0.8 mM 
15N13C cI-BABP in complex with 
unlabeled GCDA at a protein:ligand 
ratio of 1:4. Backbone sequential 
resonance assignment has been 
previously reported (19). Side chain 
resonances assignment was 
achieved for almost all atoms based 
on (H)CCH-TOCSY, H(C)CH-
TOCSY. Typically a SW of 8417.5, 
and 11312.2 was employed in the 
proton and carbon dimensions, 
respectively; 2048, 128 and 256 
points were employed in F3, F2 and 
F1, respectively. A 3D NOESY-
[1H,15N]-HSQC and two 3D 
NOESY-[1H,13C]-HSQC (one in 
H2O and one in D2O) were recorded 
to obtain intramolecular NOE-based 
distance restraints for the protein in 
the holo form.
An F1/F2-[15N,13C]-filtered NOESY 
experiment with mixing time of 70 
ms was run to filter out the 1H 
resonances of doubly labeled 
protein allowing the resonances 
assignment of ligands in the bound 
form. In order to detect 
intermolecolar NOEs between the 
labeled protein and unlabeled 
ligands, two 3D F1-[13C]-filtered, 
F2-[13C]-separated, F3-[15N,13C]-
edited NOESY spectra (one 
optimized for aliphatic and one for 
aromatic residues) were recorded in 
D2O with mixing time 120 ms.  
1H-15N HSQC spectra were 
employed in titration experiments 
where a 0.4 mM sample of 15N 
labeled protein (either wild type or 
mutants) were treated with 
increasing amounts of ligand. The 
following protein:ligand ratios were 
analysed: 1:0.3, 1:0.6, 1:1, 1:2, 
1:2.2, 1:4, 1:5. The spectra were 
acquired with a spectra width of 
7214 Hz and of 973 Hz in the 1H 
and 15N dimensions, respectively. 
2048 and 80 complex points were 
collected in F2 and F1 dimensions, 
respectively, employing standard 
pulse programs from the standard 
Bruker library. NMR data were 
processed with Topspin 2.1 
(Bruker) and analyzed with 
NMRView software (20).
Protein Structure calculation. 
Intramolecular NOE cross-peaks 
identified and integrated in the 3D 
NOESY-HSQC spectra and 
backbone dihedral angle constraints 
derived from secondary chemical 
shifts, using TALOS+ program (21) 
were used as input in the protein 
structure calculations.  
The structure of cI-BABP in the 
holo form was calculated using the 
torsion angle dynamics  program 
CYANA 2.1 (22). The CANDID 
module of CYANA (23) was used 
for automated assignment of the 
NOE cross-peaks, followed by a 
manual check prior to the final 
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calculations. In the final round of 
CYANA refinement, a total of 2738 
upper bound distance restraints and 
222 dihedral angle restraints were 
used. The 20 best structures of the 
CYANA ensemble, in terms of 
target function, were chosen to 
represent the final family. 
Structure determination of the 
protein-ligand complex. The 
structure of the ternary complex 
between cI-BABP and two 
molecules of GCDA was performed 
using the software HADDOCK 2.1 
(24) in combination with CNS (25). 
HADDOCK can dock two or more 
molecules together, incorporating 
both unambiguous (NOE, hydrogen 
bond, RDC, dihedral angle) and 
ambiguous (chemical shift 
perturbation) restraints. The 10 best 
structures of the final bundle 
calculated by CYANA were used 
for the docking calculation as 
starting protein structures. GCDA 
coordinates were derived with the 
SMILE program (26) by adding a 
glycine residue to a CDA molecule. 
Topology and parameter files of the 
ligands were generated by the 
PRODRG server (27). The protein 
was kept fully flexible during 
docking, the ligands semi flexible. 
As such, both backbones and side 
chains of the protein are allowed to 
move in the calculation. The 
following restraints were used as 
input for the docking calculation: (i) 
ambiguous interaction restraints 
derived from chemical shift 
mapping data (16) and isotope-
filtered NMR experiments; (ii) 
dihedral restraints (to maintain the 
secondary structure of the protein); 
(iii) unambiguous intra-residue 
NOEs (to ensure that the protein 
structure in the complex satisfies 
the experimentally derived 
intramolecular distances); (iv) 
intermolecular NOE-derived 
distances defined as upper distance 
limits of up to 6.0
Å between 
protein and ligand carbons.  
The docking protocol consists of 
three distinct stages: randomization 
of the relative orientations and 
energy minimization, semi-rigid 
simulated annealing of the protein 
and ligands in torsion angle space, 
and finally refinement of the 
complexes in Cartesian space with 
explicit solvent. During the rigid 
body docking, 4000 structures were 
calculated. The best 400 solutions 
were selected for a fully-flexible 
simulated annealing, followed by 
water refinement. Electrostatic and 
van der Waals terms were 
calculated with a 8.5 Å distance 
cutoff using the OPLS non bonded 
parameters from the 
parallhdg5.3.pro parameter file (28).
 The resulting solutions were 
clustered using the algorithm of 
Daura (29) with a 0.5 Å cut-off. The 
structures were divided in twelve 
clusters and the best twenty 
structures were selected for each 
cluster. According to the 
HADDOCK score we defined a 
final bundle of twenty structures. 
The protein-ligand contacts were 
analyzed using the software 
LIGPLOT (30) and the r.m.s.d. 
referred to ligand coordinates was 
calculated after all-atom fitting with 
PROFIT software (Martin, A. C. R., 
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Profit http://www.bioninf.org.uk/ 
software/profit.   
 
 
 
RESULTS AND DISCUSSION 
Solution structure determination of 
holo cI-BABP. Two-dimensional 
1H-15N heteronuclear correlation 
spectra (HSQC) of uniformly 15N 
labeled protein samples provide a 
fingerprint of the local environment 
of backbone amides and may give 
detailed insight into the structure 
and dynamics of a protein. Three-
dimensional triple-resonance 
experiments are used to extend 
these amide resonances via their 
covalently linked nitrogen into a 
third (carbon) dimension which 
finally leads to sequence 
assignments for the residues 
responsible for the original HSQC 
spectrum. On the basis of the 
standard set of 3D experiments (see 
Experimentals), a complete 
backbone assignment was 
previously obtained and reported for 
cI-BABP in complex with 
glycochenodeoxycholic acid 
(GCDA) and glycocholic acid 
(GCA) (16). We have now focused 
on the structure determination of the 
complex cI-BABP/GCDA, in order 
to investigate, at a molecular level, 
its binding characteristics, and to 
extend this analysis to a series of 
homologous holo proteins. 
The side-chains assignment of the 
complex was achieved with a set of 
3D (H)CCH-TOCSY, and H(C)CH-
TOCSY experiments while 3D 
NOESY-[1H,15N]-HSQC and 3D 
NOESY-[1H,13C]-HSQC were 
recorded to obtain intramolecular 
distance restraints. NOE cross-peak 
intensities were obtained by manual 
peak picking each strip of the 600 
MHz 3D 15N NOESY-HSQC 
spectra taken at the assigned 1H,15N 
amide resonances as well as in each 
strip of the 3D 13C NOESY-HSQC 
spectra taken at the assigned 1H,13C 
frequencies, optimized for aliphatic 
and aromatic resonances, 
respectively.
The solution structure of ileal-
BABP was then derived from 2738 
distance constraints, 221 angle 
constraints from chemical shift 
analysis by TALOS+ software (21). 
The total of 2959 constraints was 
used in generating 100 refined 
structures with the CYANA 2.1 
software, and the best 20 
conformers, those with lowest 
energy that showed the fewest 
constraint violations, were chosen 
to represent the solution structure 
of ileal-BABP (Figure 1).  
The r.m.s.d. of 0.49  ± 0.08Å for 
backbone heavy atoms and 1.07± 
0.08 Å for all heavy atoms, 86% of 
the backbone angles in most 
favoured, 14% in additionally 
favoured regions of the 
Ramachandran plot, and the 
Procheck G-factor for backbone/all 
dihedral angles of -0.62/-0.72 are 
all parameters indicative of a high 
quality solution structure. All the 
statistics and the employed tools for 
structure validation are reported in 
Table 1.  
Identification of intermolecular 
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restraints. We have previously 
shown, on the basis of NMR and 
calorimetry data that the protein 
forms a ternary complex with two 
ligand molecules. One of the most 
difficult problems to be solved for a 
ternary complex like that of cI-
BABP/GCDA is the assignment of 
the two identical bound molecules 
of the unlabelled bile acids. The 
chemical shift dispersion of protons 
belonging to GCDA is very poor, 
but the presence of three methyl 
groups (C18, C19 and C21) which 
appear as two high intensity 
singlets at relatively high fields 
(reported chemical shifts for C18 
and C19 are 0.67 and 0.93 ppm, 
respectively) and as a doublet (C21, 
0.95 ppm) (Figure 2 a,b) 
constituted a good entry point for 
the assignment of the bound 
molecules.  2D F1/F2-[15N,13C]-
filtered NOESY experiments, 
performed on a cI-BABP/GCDA 
complex at different protein:ligand 
ratio (from 1:1 to 1:4) were used to 
eliminate 1H signals belonging to 
the protein, which is 15N and 13C 
labelled, thus giving the possibility 
of observing only the unlabelled 
bound and unbound ligands. 
Although it is suggested that a 
sample requirement for isotope-
filtered experiments is that the 
partners should be present in near-
stoichiometric ratio, experiments at 
different protein:ligand ratios were 
employed in the present study, to 
keep track of the different species 
present at each r ratio. At P:L 1:4 
three new broad signals occurring 
at 0.15, 0.19 and 0.42 ppm were 
thus identified (see Figure 3a for 
the 1:4 P:L complex). They 
exhibited NOESY exchange peaks 
with intense signals at the same 
chemical shift of free GCDA (in 
excess in the complex), whose 
resonance assignment is known 
(31). Thus the assignment of 
methyl signals of one bound GCDA 
molecule (hereby called GCDA-II) 
was obtained (Figure 3a). 
Specifically the identification of 
C19 and C21, nearly superimposed 
in the free ligand, was possible on 
the basis of the double filtered 
TOCSY experiment of the 
complex, where the only methyl 
residue exhibiting a scalar 
correlation can be that 
corresponding to C21 (scalarly 
coupled to H20 and H17) (Figure 
3b). However, if two molecules of 
GCDA are bound to cI-BABP, then 
a total of six different methyl 
signals are expected in this region, 
in addition to those of free GCDA. 
As shown in Figure 3b it is likely 
that the resonances belonging to the 
second bound ligand are 
superimposed to those of free 
GCDA. Further experiments 
confirmed that at P:L ratio 1:4 the 
resonances of the ligand bound at 
site I are coincident with those of 
the free ligand: i) 1H-15N HSQC 
spectra obtained from the complex 
of the unlabelled protein with 15N 
labelled GCDA showed a unique 
resonance at 7.89 ppm for the 
amide group of the free ligand and 
of the ligand bound to site 1; ii) 
HACA and HNCA 3D spectra 
obtained from the complex of 
unlabelled protein with the 15N,13C 
glyco-conjugated bile salt, 
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exhibited a unique  Cchemical 
shift for the free and bound (to site 
1) ligand. (Figure 1 of 
Supplementary Material). Titration 
experiments obtained upon addition 
of increasing amount of 15N 
labelled GCDA to the unlabelled 
protein showed that the amide of 
ligand bound to site I exhibits fast 
exchange with free GCDA and 
move towards the chemical shift of 
free GCDA amide during the 
titration (Figure 2 of 
Supplementary Material). We 
reasoned that in the presence of an 
excess of ligand, exchange 
phenomena with the free ligand are 
enhanced, thus allowing for the 
assignment, while at lower 
protein/ligand ratio the sets of 
bound methyl groups in both singly 
and doubly ligated complexes 
should be the prominent species 
and therefore more easily 
distinguishable. Indeed, we have 
previously shown that the ITC-
derived model, implying the 
presence of two consecutive 
binding sites, predicted a 
considerable concentration of 
singly ligated protein in a wide 
range of ligand–protein molar 
ratios, accounting for 
approximately 50 % of all protein 
in the range of 1:1 <P:L<1:2 (19).  
However, 1H-13CHSQC protein 
spectra obtained at increasing 
amounts of ligand, showed the 
appearance of only two sets of 13C 
separate signals. Thus, in those 
spectra, the singly bound protein 
was either invisible in the 
employed experimental conditions, 
or its signals coincident with one of 
the two sets of resonances, as was 
established by comparing the sum 
of the population fractions for both 
the unbound and singly bound 
forms and for both the singly and 
doubly bound forms with the signal 
intensities of the two set of 13C 
signals. The following analysis 
performed at different P:L values 
allowed for the possible 
identification of the singly ligated 
species. Indeed at P:L 1:2 (Figure 
4) an intense cross-peak in the 2D 
F1/F2-[15N,13C]-filtered NOESY 
experiment connected the 
resonances at 0.42 and 0.57 ppm. 
We hypothesized that the methyl 
resonance of a singly ligated 
species (indicated in the Figure as 
18sb) overlaps with the assigned 
C19 of GCDA-II.  Thus this cross-
peak represents an exchange cross-
peak with the resonance occurring 
at 0.57 ppm, corresponding to C18 
free ligand superimposed to C18 of 
GCDA-I. In Figure 4 the 
resonances of the other methyl 
groups corresponding to the ligand 
bound to site 1, to the singly bound 
species and to the free ligand are 
indicated. This assignment is 
confirmed by the fact that upon 
increasing the P:L ratio this cross-
peak disappears. Indeed on going 
from P:L 1:1 to P:L 1:5 the 
population of the singly ligated 
species decreases and the 
resonances of the coincident free 
and bound-to-site-1 methyl groups 
move downfield towards the free 
ligand chemical shift (the ligand at 
site 1 is in fast exchange with the 
free ligand) (see Figure 3 of 
Supplementary Material).   
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Complementary NMR experiments, 
namely F1-edited, F3-filtered 3D 
HMQC-NOESY (32), with mixing 
times ranging from 0 to 200 ms, 
were then performed, in order to 
specifically detect signals of bound 
GCDA and eliminate those of the 
free form. In these experiments, 
only 1H signals of GCDA 
experiencing NOE with the protein 
can be detected. All the parameters 
of the experiments were optimized 
to minimize the signals in the 
region 0-1 ppm at zero mixing 
time, where all the resonances 
should be filtered out. A 
superposition of the high field 
region of the spectra at P:L 1:2 
obtained from the first FIDs at all 
mixing times is reported in Figure 
5, clearly showing all the methyl 
groups (labelling is reported in the 
Figure) of the doubly and singly 
ligated species. All the spectra 
experience increasing NOE effects 
upon increasing the mixing time. 
All these data indicate that 
simplified spectra are obtained at 
higher P:L ratio due to the presence 
of a higher population of the 
doubly ligated species, and 
therefore the whole set of 3D 
experiments aimed at obtaining the 
assignment of the holo protein were 
performed at P:L ratio 1:4. Other 
resonances, beyond those of the 
bound methyl groups, could be 
unambiguously assigned at P:L 1:4 
ratio, namely the resonances of H7 
(H7 GCDA-I 3.85 ppm, H7 
GCDA-II 3.89 ppm), as they occur 
outside of the bulk of the ligand 
resonances.  H3 of GCDA-1 could 
be unambiguously identified at 3.46 
ppm, as well as H25 of the bound 
species. These assignments allowed 
the identification of several 
intermolecular NOEs in the 3D F1-
[13C]-filtered, F2-[13C]-separated, 
F3-[13C]-edited NOESY-HSQC 
spectra (Figure 6). The number of 
the identified intermolecular 
constraints was initially rather 
limited (35) and not devoid of 
ambiguities, as the chemical shifts 
of GCDA-I C19 and C21 are 
substantially superimposed.  
As a record, it should be stressed 
that an analysis of the singly ligated 
species occurring at protein:ligand 
ratio 1:2 was hampered by the 
complexity of the spectra under 
examination. It is however worth 
mentioning that intermolecular 
NOEs were detected between the 
resonance occurring at 0.57 ppm 
(assigned to a singly ligated 
species) and residues located at the 
protein open end (30, 31, 34, 36, 
53), thus suggesting that a singly 
bound species would involve the 
more superficial binding site, as 
previously shown for homologous 
proteins (33,34). At the same time 
the available data may not rule out 
that such interaction involves the 
protein surface giving rise to an 
adsorbed intermediate which later 
mature by migration of the ligand 
into a more specific binding site. 
Analysis of the histidine tautomeric 
state.  Additional experiments were 
run to investigate the histidine 
protonation state in the present 
experimental conditions. We have 
already pointed out the role of 
buried histidines in the binding 
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mechanism in other proteins of the 
family (13,35). To identify possible 
H-bonds between histidines and 
bound ligands it is relevant to know 
which tautomeric form is present, 
so to introduce the correct 
information on the histidine state in 
the computation procedure. Indeed 
the non-exchangeable H2 and H1 
protons, linked to nitrogen via 
weak two and three-bond 
couplings, can be detected in 1H-
15N HMBC experiments (36-38). 
Specific assignment of 1H and 15N 
resonances of H52 and H98 were 
thus obtained, coupling the 
information derived from 1H-15N 
HMBC with 1H-13C HSQC-CT 
experiments, acquired in constant 
time (which removes the 
homonuclear coupling) and 
optimised for the aromatic 1H-13C 
coupling. In these experiments C4-
H2 correlations of histidine 
residues have negative sign 
(together with C2-H2 of tryptophan 
residues) and are thus easily 
identified. (Figure 4 of 
Supplementary Material). On the 
basis of the observed pattern and 
15N and 1H shifts it appears that 
H52 and H98 are protonated and 
charged, as they exhibit a N value 
of 173.2 ppm, expected for type + 
15N. Their H1 and H2 protons are 
also downfield shifted, as expected 
for charged protonated histidines. 
Interestingly, only the resonances 
of H52 and H98 are detectable in 
1H-15N HMBC spectra, while H99 
resonances are not present, possibly 
due to exchange broadening 
between two tautomeric forms (N-
H2 and N-H2), occurring on a 
time scale comparable to the 
expected chemical shift difference 
between type and type  
nitrogens (82 ppm). C4-2 
resonance of H99 is however 
present in the 1H-13C HSQC-CT 
spectrum, with H2 occurring at 
6.09 ppm, consistent with the 
presence of a neutral histidine. 
Additionally 1H NMR spectra 
revealed the presence of an NH 
resonance at 12 ppm, which could 
be unambiguously assigned to the 
proton directly attached to the 
imidazole ring nitrogen (as deduced 
from 1H NOESY spectra showing 
the correlation of N-H with H1 
at 7.67ppm and H2 at 6.09 ppm). 
NH resonance is usually lost as it 
exchanges too quickly with water 
proton. Thus the unusual presence 
of N-H resonance confirms that 
H99 is deeply buried in the protein 
cavity, possibly involved in H-
bonds with the ligand. 
Structure calculation of the ternary 
complex between cI-BABP and two 
molecules of GCDA. The procedure 
selected for structure calculation 
employed Haddock (18), a robust 
data driven modelling program. 
The ability of Haddock in exploring 
the protein-ligand conformational 
space has been widely recognized, 
however only a limited number of 
studies are present in the literature 
where this approach is employed 
for the identification of a complex 
between a protein and small ligands 
(24,39-41). In our approach, to 
ensure success of the docking 
procedure, the starting structure for 
ligand docking was the calculated 
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structural ensemble of the holo 
protein. Therefore 2738 
intramolecular NOEs were defined 
as non-ambiguous interaction 
restraints while 221 dihedral angles 
derived from secondary chemical 
shifts were employed to maintain 
the secondary structure of the 
protein. To identify the interaction 
surface, the average chemical shift 
changes between the free and the 
bound state, as derived from a 
series of 1H,15N-HSQC spectra 
collected upon progressive addition 
of GCDA, were plotted versus the 
cI-BABP residue numbers 
(Figure7). Resonances with 
significant chemical shift 
perturbation (CSP), deviating more 
than two standard deviation from 
the mean CSP, included residues 
53, 57-59, 97, 98 indicating that the 
interaction of cI-BABP with 
GCDA clearly affects residues in 
CD loop and in the  H -strand. 
These residues were therefore 
categorized as “active” and 
assigned as ambiguous interaction 
restraints (AIRs), which require 
their interaction with the substrate. 
Intermolecular NOEs, derived from 
edited-filtered experiments, were 
all used as ambiguous restraints 
(AIRs) in the first Haddock run. 
For these last constraints no 
calibration of the peak volumes was 
performed, as the filtered 
experiments do not provide signals 
corresponding to known distances, 
and an upper limit distance of 6 Å 
was employed. Histidines were 
defined as charged or non charged 
as mentioned in the previous 
paragraph. Subsequent rounds of 
Haddock procedure coupled with 
spectral analysis led to the 
identification of 48 non-ambiguous 
constraints between the ligands and 
the protein from which the structure 
of the complex was derived. A 
complete list of ambiguous and 
non-ambiguous restraints is given 
Table 2. A total of 400 structures of 
the complex were selected after 
rigid body docking and subjected to 
optimization by fully flexible 
simulated annealing, followed by 
refinement in explicit water. These 
structures were then clustered 
according to their pairwise root-
mean- square deviation values, and 
the twenty lowest energy structures 
in the lowest energy cluster were 
selected. Statistics of the cluster 
with the best average HADDOCK 
score are presented in Table 3 
while Figure 8 displays the 
HADDOCK model that represents 
best the structure of the complex. 
The twenty best structures in the 
selected cluster have an average 
backbone RMSD value from the 
mean of 0.044 ± 0.09 Å and 0.95 ± 
0.10 Å for the backbone and all 
heavy atoms, respectively. The 
average r.m.s.d of the ligands, 
obtained with Profit, were 1.15 Å 
for GCDA-I and 0.72 Å for GCDA-
II.  The protein-ligands interface 
was analysed using Ligplot (30) 
(Figure 9).  
Structural comparison with other 
proteins of the family. Only another 
ileal BABP structure from 
zebrafish forming a ternary 
complex with bile acids (pdb 
3ELZ) is available for structural 
comparison. Few additional data 
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are available relative to the 
thermodynamics of binding for 
human (10), zebrafish (11) and 
rabbit ileal BABPs (12,42). The X-
ray structure of the zebrafish 
protein shows that in two out of the 
three protein molecules present in 
the asymmetric unit, there are three 
cholate molecules in approximately 
identical position bound on the 
surface of the protein, in addition to 
the two internal ligands. We have 
previously shown, on the basis of 
NMR and calorimetry data that cL-
BABP displays a 1:2 stoichiometry 
(13,43). We will therefore focus on 
the comparison of the internal 
binding pocket. Superposition of 
ileal zebrafish BABP (3ELZ) with 
the cI-BABP here reported, yielded 
r.m.s.d. values of 1.94 Å and 
indicated that helix-II, EF and IJ 
loops in zebrafish are substantially 
different from the chicken protein. 
These structural elements define 
the protein open end, which can 
determine the orientation of the 
more external ligand (GCDA-I) and 
eventually influence the binding 
cooperativity. Indeed, while the 
internal ligand (GCDA-II) has a 
very similar orientation in the two 
proteins, the external GCDA-I 
exhibits different orientations. To 
better analyse the surface binding 
cavities, Ligplot results obtained 
for zebrafish and ileal BABPs were 
compared (Figure 9). When the 
internal GCDA-II is considered, it 
appears that in the chicken protein, 
in at least 15 structures of the 20 
analysed, favourable hydrophilic 
interactions (H-bonds) are formed 
between the carboxylate side chain 
of the ligand and residues T73, G75 
and R77. Residues 73, 75 and 77 
(including EF loop) are conserved 
in the entire protein family (residue 
77 is R in the chicken ileal protein 
and lysine in all the remaining 
members of the family). In 
zebrafish holo protein the bound 
ligands are cholate molecules (CA), 
exhibiting shorter side chains 
terminating at C24 and an 
additional hydroxyl group in 
position 12. Internal cholate shows 
hydrophilic interactions between 
C24 carboxylate and V74 (EF 
loop), OH in position 12 and Y97 
(strand H), OH in position 7 and 
E110 (strand I). A common 
anchoring point for the internal 
ligand in the two proteins is thus 
located at the level of EF loop. 
GCDA-I, in the chicken protein, 
has two H-bonds between the 
carbonyl group of C24 and the side 
chain of K27, the terminal 
carboxylate and the backbone 
amide of R57. In the zebrafish H-
bonds involve OH7 and the side 
chain of Y53, OH12 and the side 
chain of Y14. When the 
hydrophobic interactions are 
compared, the internal cholate in 
zebrafish establishes hydrophobic 
interactions with Y97, F79, T73, 
M71, F63, N61, W49 and the 
external ligand with V74, Y53, 
G31, I23, and I21. The same 
analysis performed for the twenty 
Haddock structures of cI-BABP 
indicated that residues involved in 
hydrophobic interactions (present 
in at least 18 structures out of 
twenty) with GCDA-II are H99 
(either H or Q in the family), Y97, 
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F94 (either F or S), A92, V83, F79, 
R77, G75, T73, M71, F63, N61, 
W49 and with GCDA-I are G75, 
M74, F53, M30, K27, L23 (either L 
or I), I21 (either I or L). The 
underlined residues are those 
conserved throughout the family. 
This analysis indicates that 
substantially the same residues are 
involved in the interaction with the 
internal ligand, though a more 
extended hydrophobic environment 
for GCDA-II is present in cI-
BABP, consistent with the 
increased hydrophobicity of GCDA 
with respect to cholate. This 
analysis shows that the more 
pronounced differences in binding 
interface involve the environment 
of the external ligand.
Structural correlates of 
cooperativity: phylogenetic analysis 
of iLBP family. Sequence retrieval 
of the entire iLBP family was 
performed using both BLAST and 
Ssearch programs over the 
UNIPROT database. A multiple 
sequence alignment of the family 
was then obtained with the 
PROMALS program. The obtained 
alignment was then funnelled 
through the procedure of 
phylogenetic tree building using the 
MEGA program. Different 
approaches were used to the 
construction of the phylogenetic 
trees from the multiple sequence 
alignment, i.e. like Neighbour 
Joining, Minimum Evolution, 
UPGMA Maximum Parsimony and 
Maximun Likelihood, and an 
afterwards tree comparison was 
performed taking into account the 
work by Schaap (44). Figure 10 
reports the obtained tree of the 
entire family.  The classification has 
been done with a tissue specific 
criterion and each cluster contains 
proteins coming from the same 
tissue but from different species. A 
detailed analysis of the clusters 
indicates that the tissue-
specialization of the proteins 
occurred before speciation. When 
the subfamilies of interest in the 
present work, i.e. liver FABPs, liver 
BABPs, and ileal BABPs are 
considered, it appears that the three 
groups are well separated. 
Interestingly the liver FABP group 
includes only mammalian species, 
the liver BABP group includes only 
non-mammalian species while the 
ileal BABP group includes both 
mammalian and non-mammalian 
species. Thus, for the analysis of the 
cI-BABP and its putative functional 
aminoacids, we concentrated on its 
closests relatives, that is the I-
BABP family. In order to 
investigate the determinants of 
cooperativity between binding sites, 
detailed structural data, as those 
provided here, are of fundamental 
importance, as only the analysis of 
the sequences and functional 
conservation of certain features may 
allow the characterization of the key 
residues in the binding mechanism.  
This approach should further allow 
the design of mutations able to 
produce a gain of function, i.e. 
moving from a non-cooperative to a 
more cooperative protein. Figure 11 
reports the sequence alignment of 
chicken, human, rabbit and 
zebrafish I-BABPs. As it is not 
straightforward to correlate the 
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occurring substitutions with the 
trends in binding cooperativity, we 
first performed a comparison of 3D-
structures from chicken (non 
cooperative binding) and human 
(high cooperative binding) proteins. 
The human holo structure reported 
in the PDB (1O1V) is bound to a 
single ligand, as it was obtained at 
temperatures where the observation 
of one of the two ligand molecules 
was hampered by NMR exchange 
broadening (14,45). However we 
believe that the protein structure 
itself can be employed for structural 
comparison, while interaction data 
later reported for human ileal ILBP 
(8,9,46) were used when comparing 
protein-ligand interactions. We 
looked first at the non conserved 
aminoacids, in order to possibly 
select for those residues with lost or 
gained interactions. Among these, 
we discarded those residues that do 
not point into the internal cavity. 
The remaining residues were 
mapped onto the sequence 
alignment to extend the analysis to 
the other homologouos proteins 
with the purpose of identifying 
whether a correlation between the 
selected aminoacids and the 
decrease/increase of cooperativity 
exist. As it was not straightforward 
to single out aminoacids eventually 
involved in cooperativity, we went 
on analysing pairs of aminoacids.  
The 11 non conserved residues 
within the protein cavity may give 
rise to 55 possible pairs. Of these 
only eight pairs were made of 
residues exhibiting a reciprocal 
average distance shorter than 4 Å 
and, more specifically, six pairs, 
namely 53-54, 53-34, 54-34, 24-27, 
27-30, 30-34 were found both in 
human and chicken proteins (Table 
4). Although only the pairs 54-34 
and 24-27 appear to change together 
with cooperativity effects, the kind 
of interaction formed in human and 
chicken proteins is conserved. 
Indeed, in both cases, the 
interactions are hydrophobic and do 
not involve their functional groups. 
In particular for the 54-34 pair P54, 
in chicken, interacts with H of 
C54 (not with SH). Similarly H of 
S54, in human species, interacts 
with H atom of F34. For the 24-27 
pair, chicken P24 interacts with the 
aliphatic chain of K27 and human 
S24 H (not OH) interacts with a 
methyl group of V27. Furthermore, 
two pairs 54-27 and 99-101 were 
present only in the human protein, 
with only the 99-101 pair 
correlating with cooperativity 
effects (Table 4). Residues 99 and 
101 are buried within the protein 
cavity, with H99 being the only 
residue making contacts with both 
ligands in chicken ileal protein. The 
pair 99-101 wit exception of ileal 
protein, is always made by polar 
residues, Q/T and H/S, in the 
intermediate cooperative zI-BABP 
and rI-BABP and Q/S in the human 
protein. As a likely way of energetic 
communication between the two 
binding sites shoud involve a 
hydrogen-bonding network, we 
reasoned that that disruption of such 
network may affect cooperativity. 
We thus looked for conserved H-
bonds involving side chains in 
human and chiken ileal BABPs. The 
H-bond between Q99 and S101 (in 
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human) could not be formed in the 
ileal protein, where residue 101 is 
an alanine. Calorimetry data 
coupled to mutation data reported 
for the human protein in complex 
with GCDA indicated that the 
mutant Q99A exhibited a strong 
decrease in cooperativity for the 
binding to GCDA (8).  It should be 
noted that the 99-101 H-bond is 
conserved also in the zebrafish 
species, where the pair T/Q is 
present. Altogether the ensamble of 
these data sugegsted that a key 
mutation could be located at the 
level of the buried pair 99/101. 
Mutant analysis. Two mutants were 
then designed and enginereed, the 
single mutant cI-BABP A101S  (to 
mimic the intermediate co-
operativity as in rI-BABP) and the 
double mutant cI-BABP 
H99Q/A101S to mimick the optimal 
couple Q/S found in the human 
protein. The mutated proteins were 
then titrated with increasing amount 
of 15N labelled GCDA, in the 
assumption that gaining of the 
cooperative function should lead to 
the observation of GCDA-II amide 
resonance at P:L ratio lower than 2. 
This at variance with the behaviour 
observed for the wild type protein 
where, as a result of a consecutive 
binding, resonance of ligand 2 only 
appeared in the HSQC spectrum at 
protein:ligand ratio higher that 2. 
Figure 12 reports a comparison of 
the titration experiments performed 
for the wild-type and the two 
mutants A101S and H99Q/A101S. 
A similar behaviour is substantially 
displayed by the wild-type and the 
A101S mutant, while a clear gain in 
cooperativity is obtained for the 
double mutant where the resonances 
corresponding to the two bound 
species are already present, at their 
final chemical shifts (i.e the 
chemical shifts of the saturated 
species), at a P:L ratio 1:1. This 
behaviour is a clear indication that 
the binding mechanism has changed 
and the two binding events are no 
more consecutive and independent.  
Bile acid production is 
stimulated pri- marily by bile acids 
returning to the liver and is also 
influenced by the size of the bile 
acid pool and number of 
enterohepatic circulation cycles. It 
should be mentioned that in humans 
primary bile acids include both tri-
hydroxy and di-hydroxy conjugates 
in approximatively 55 to 35% ratio, 
respectively (6), while, in avians, 
glycine and taurine CDA conjugates 
(47) represent 70–95% of the bile 
salt pool (48). In vitro studies have 
clearly established that conjugates 
of cholic acid, containing three 
hydroxyl groups on the steroid 
nucleus, are intrinsically less 
cytotoxic than conjugates of CDA, a 
dihydroxyl bile acid. It has been 
suggested that the addition of a third 
hydroxyl group has evolved, 
through six types of nuclear 
hydroxylation pathways, as a means 
of detoxifying CDA. The toxicity of 
high concentration of CDA, on one 
side, further suggests the important 
role of I-BABPs in the regulation of 
bile salts concentration in the cell, 
and, on the other side, may explain 
the adaptative response of evolving 
a single protein system capable of 
binding at the same time (site 
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seletivity) and with high efficiency 
(cooparativity) different 
components of the bile acid pool. To 
this aim an efficient network of 
hydrogen bonds must be established 
and the 99-101 pair is indeed part of 
an extended network which allows 
the establishment of  
communicationacross the protein 
(Figure 13). It has also been 
reported that the  hydrophobic-
hydrophilic balance of the pool that 
results from the characteristics and 
proportions of the individual bile 
acids present within the pool is 
critical as it may dictate most of the 
effects of bile acids on hepatic 
cholesterol metabolism where more 
hydrophobic bile acids seem to 
increase biliary lipid secretion and 
inhibit cholesterol and bile acid 
synthesis, whereas hydrophilic bile 
acids are less effective (4). 
It is thus clear that the 
knowledge of the subtle structural 
and dynamic effects regulating the 
binding mechanism of bile salt 
derivatives may give an important 
contribution to the understanding, in 
molecular terms, of the link 
between metabolic diseases.  
. 
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FIGURE LEGENDS 
Fig. 1. Superposition of the twenty lowest energy structures obtained for 
cI-BABP employing CYANA 2.1. 
 
Fig. 2. 1D 1H NMR spectrum recorded at 600.13 MHz of a 1mM sample 
of GCDA in 30 mM phosphate buffer at 298K (a); Structure of GCDA 
with the numbering of atoms. 
 
Fig. 3. High field region of the 2D F1/F2-[15N,13C]-filtered NOESY 
spectrum of 0.4 mM sample of cI-BABP in complex with GCDA at a P:L 
ratio 1:4. The sample was dissolved in 30 mM phosphate buffer, pH 6.5, 
298K. The employed mixing time was 70 ms. The assignments are 
reported on the spectrum (a); High-field region of the 2D F1/F2-[15N,13C]-
filtered TOCSY recorded with an isotropic mixing of 70 ms. Assignments 
are reported on the spectrum (b). 
 
Fig. 4. High field region of the 2D F1/F2-[15N,13C]-filtered NOESY 
spectrum of 0.4 mM sample of cI-BABP in complex with GCDA at a P:L 
ratio 1:2. The experimental conditions are the same reported in the caption 
of Fig.2. Assignments are reported on the spectrum. 
 
Fig. 5. High field region  observed in the transformed first fid of the F1-
edited, F3-filtered 3D HMQC-NOESY. Only resonances of protons bound 
to 12C and exhibiting NOEs with protein are present. Experiments were 
performed at increasing mixing times: 0 ms (black), 80 ms (red), 100 ms 
(green), 120 ms (magenta), 150 ms (yellow) and 200 ms (orange). 
 
Fig. 6. F1-F3 slices of the 3D F1-[13C]-filtered, F2-[13C]-separated, F3-
[13C]-edited NOESY-HSQC spectrum of cI-BABP/GCDA complex at a 
1:4 molar ratio. The protein sample was 0.8 mM. The left upper panel 
corresponds to the chemical shift of I28-CThe right upper panel 
corresponds to the chemical shift of G75-CThe left lower panel 
corresponds to the chemical shift of M73-C The right lower panel 
corresponds to the chemical shift of M71-C All NOEs with the ligands 
atoms are indicated.  
 
Fig. 7. Plots of the chemical-shift differences relative to unbound protein 
and protein bound to GCDA; Residues exhibiting a chemical shift 
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perturbation above two standard deviations are T53, R57, T58, T59, Y97 
and H98. 
 
Fig. 8. Superposition of the twenty lowest energy structures belonging to 
the best Haddock- score cluster. The internal ligands are represented as 
sticks in red. 
 
Fig. 9. Ligplot two-dimensional representation of interactions observed 
among GCDA-I, GCDA-II and cI-BABP. Hydrogen bonds are depicted 
with dashed green lines and hydrophobic interactions are shown as red 
arcs. 
 
Fig. 10.  	
  	 	   

	
 
Fig. 11. Sequence alignment of chicken I-BABP with human, rabbit and 
zebrafish I-BABPs. Conserved residues are highlighted in bold. Residues 
presenting non-conservative mutations in the four proteins pointing 
towards the ligand-binding cavity, as identified by the program CASTP 
(http://sts.bioengr.uic.edu/castp/) are indicated with a circle.  
 
Fig. 12. 1H-15N-HSQC spectra registered during the titration of cI-BABP 
with 15N-GCDA at different molar ratios, indicated in each panel (A); 
titration of A101S mutant (B); titration of A101SH99Q mutant (c). 
 
Fig. 13. Ribbon drawing of human ileal bile acid binding protein (pdb 
1O1V) showing the network of hydrogen bonds crossing the entire 
protein. The name of the involved residues is reported. 
 
Fig. S1. 1H-15N-HSQC spectrum recorded on 0.4 mM sample of 
unlabelled cI-BABP in complex with 15N13C-GCDA at a P:L ratio 1:4 (a); 
HNCA spectrum recorded on the same sample (b). The GCDA molecule 
bound to the site 1 (GCDA-I) and the free GCDA exhibit a unique C 
chemical shift. 
 
Fig. S2. Superimposition of 1H-15N-HSQC spectra of a sample 
containing unlabelled chicken I-BABP and  15N13C-GCDA in the 
following protein:ligand ratios: 1:0.3, 1:1, 1:1.5, 1:2.2, 1:5. Arrow follows 
the direction of peak shifts corresponding to ligand bound to site 1, which 
moves towards the chemical shift of free GCDA. 
 
Fig. S3. Superimposition of high field regions of the 2D F1/F2-[15N,13C]-
filtered NOESY spectra of a sample of doubly labelled cI-BABP and 
unlabelled GCDA in the following protein:ligand ratios: 1:2 (black), 1:4 
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(blue), 1:5 (red). Arrows follow the direction of peak shifts corresponding 
to the coincident free and bound-to-site-1 (GCDA-I) methyl groups 
moving downfield towards the free ligand chemical shift. 
 
Fig. S4. The spectra highlight the observed correlations of histidine atoms. 
the adduct involving aromatic residues. 1H13C HSQC-CT experiment 
recorded on 0.4 mM sample of cI-BABP in complex with GCDA at a P:L 
ratio 1:4. The assignments are reported on the spectrum (a); 1H-15N 
HMBC experiment recorded on the same sample. The assignments are 
reported on the spectrum (b); 2D from 1H1H NOESY spectrum showing 
the only observable correlations of  H99. The assignments are reported on 
the spectrum (c).  
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aRoot mean square deviations of atomic coordinates were calculated over residues 
1-127 using MOLMOL. bCalculated for all constraints for the given residues, 
using sum over r^-6. cLargest constraint violation among all the reported 
structures. dWithin 1.6 Å for H atoms, 2.2 Å for heavy atoms. e Z-Score computed 
by PSVS. 
 
 
Table 1. Statistics for the Final Structural Ensemble Obtained 
average rmsd (Å) 
?rmsd? backbone (C, NH, and C')a                         
?rmsd? heavy atoms                                                 
0.49 + 0.08 Å 
1.07 + 0.08 Å 
experimental restraints               
 short-range NOEs ( |i-j| < 1) 
 medium-range NOEs (1 < |i-j| < 5)  
 long-range NOEs ( |i-j| > 5) 
 total 
 dihedral angle restraints  
1342 
361 
1035 
2738 
221 
experimental restraints violationsb
 Distance violations / structure  
 0.1 - 0.2 Å 
 0.2 - 0.5 Å 
      > 0.5 Å 
 RMS of distance violation / constraint 
 Maximum distance violationc                                
 
5.2 
0.6 
0  
0.01 Å 
0.31 Å 
 Dihedral angle violations / structure  
 1 - 10 ° 
   > 10 ° 
 RMS of dihedral angle violation / constraint  
 Maximum dihedral angle violationc  
 
2.65  
0 
0.20 ° 
3.40 °  
Ramachandran analysis 
 Residues in the favoured region (%) 
 Residues in  allowed regions (%) 
 Residues in generous regions (%) 
 Residues in disallowed regions (%) 
86.1 
13.9 
0 
0 
Close Contacts and Deviations from Ideal Geometry (from PDB validation software)
 Number of close contactsd 
 RMS deviation for bond angles 
 RMS deviation for bond lengths 
0 
0.2 ° 
0.001 Å 
Global quality score 
 Program          Verify3D ProsaII(-ve) Procheck(phi-psi) Procheck(all) MolProbity 
Clashscore 
 Raw score      0.47 0.52 -0.62 -0.72 16.68  
 Z-scoree           0.16 -0.54 -2.12 -4.20 -1.34 
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Table 2. Ambiguous and non-ambigous intermolecolar restraints used  to calculate the structure of the complex 
Ambiguous interaction restraints 
Non-ambiguous interaction restraints 
Protein atom Ligand atom 
F17 (NOE)a 
V18 (NOE) 
I21 (NOE) 
L23 (NOE) 
I28 (NOE) 
M30 (NOE) 
I36 (NOE) 
F53 (CSP,NOE) 
R57 (CSP,NOE) 
T58 (CSP) 
T59 (CSP) 
N61 (NOE) 
A69 (NOE) 
M71(NOE) 
T73 (NOE) 
M74 (NOE) 
G75 (NOE) 
F79 (NOE) 
A81 (NOE) 
V83 (NOE) 
A92 (NOE) 
F94 (NOE) 
Y97 (CSP) 
H98 (CSP) 
Y119 (NOE) 
F17, C C3 GCDA-I 
F17, C C7 GCDA-I 
V18, C Me18 GCDA-I 
V18, C Me19 GCDA-I 
I21, Cand C Me19 GCDA-I 
L23, C Me18 GCDA-I 
L23, C Me19 GCDA-I 
L23, C C25 GCDA-II 
I28, Cand C Me18 GCDA-I 
M30, C, Cand C  Me21 GCDA-I 
M30, C C25 GCDA-I 
I36, C  Me21 GCDA-I 
F53, C, C, CandC Me21 GCDA-I 
R57, C C25 GCDA-I 
N61, Cand N2 C7 GCDA-II 
N61, C Me19 GCDA-II 
A69, C Me19 GCDA-II 
M71, C Me18 GCDA-II 
M71, C Me19 GCDA-II 
M71, C C7 GCDA-II 
T73,  C C7 GCDA-I 
T73,  C C25 GCDA-II 
M74, C Me21 GCDA-I 
G75, C C7 GCDA-I 
G75, C C25 GCDA-II 
F79, Cand C Me18 GCDA-II 
F79, Cand C Me19 GCDA-II 
F79, Cand C C7 GCDA-II 
A81, C Me18 GCDA-II 
A81, C Me19 GCDA-II 
V83, C Me19 GCDA-II 
A92, C Me18 GCDA-II 
A92, C Me19 GCDA-II 
F94, Cand C Me18 GCDA-II 
F94, Cand C Me19 GCDA-II 
Y119, C C3 GCDA-I 
aThe experimental method used to define the residue as active is indicated in 
parenthesis. 
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Table 3. Structural Statistics of twenty lowest energy structures in the lowest energy cluster 
average rmsd (Å) 
?rmsd? backbone (C, NH, and C')a                         
?rmsd? heavy atoms                                                 
0.44 + 0.08 Å  
0.95 + 0.10 Å  
Backbone RMSD (Å) with respect to mean               
  Flexible interface backbone 
  All backbone  
0.29 + 0.09 Å  
0.32 + 0.13 Å  
Experimental restraints  
 Number of ambigous interaction restraints 
 Number of intermolecular interaction restraints  
 Number of intramolecular interaction restraints 
 Number of dihedral angle restraints 
 
Restraints violations 
 
Total ambigous  violations                                                                                       
Total unambigous  violations 
Intramolecular distance violations / structureb  
 0.1 - 0.2 Å 
 0.2 - 0.5 Å 
      > 0.5 Å 
Dihedral angle violations / structure  
 1 - 10 ° 
   > 10 ° 
49 
48 
2738 
221 
 
 
 
1 
0 
 
0.15 
0 
0 
 
10 
0 
Intermolecular energies after water refinement 
 
Evdw (kcal mol-1)         
Eelec (kcal mol-1)        
 
 
-61.66 + 3.35 
-282.4 + 36.22 
Buried surface area (Å2)                   1663.37 +27.24 
Ramachandran analysis 
 Residues in the favoured region (%) 
 Residues in  allowed regions (%) 
 Residues in generous regions (%) 
 Residues in disallowed regions (%) 
91.4 
8.6 
0 
0 
Close Contacts and Deviations from Ideal Geometry (from PDB validation software)
 Number of close contactsc
 RMS deviation for bond angles 
 RMS deviation for bond lengths 
37 
0.6 ° 
0.005 Å 
  
aRoot mean square deviations of atomic coordinates were calculated over residues 
1-127 using MOLMOL. bCalculated for all constraints for the given residues, 
using sum over r^-6. cWithin 1.6 Å for H atoms, 2.2 Å for heavy atoms.  


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Table 4. Pairs of non conserved residues that show recoprocal interactions 
Residue 
pair 
cI-BABP 
residues 
zI-BABP 
residues 
rI-BABP 
residues 
hI-BABP 
residues 
53-54 F-P Y-P Y-S Y-S 
53-34 F-C Y-K Y-I Y-F 
54-34 P-C P-F S-I S-F 
24-27 P-K P-V P-V S-V 
27-30 K-M V-K V-K V-K 
30-34 M-C K-F K-I K-F 
54-27a P-K P-V S-V S-V 
99-101a H-A Q-T H-S Q-S 
G -0.87 -4.55 -6.96 -15.50 
a Residue pair displays interactions only in human I-BABP. 
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Conclusions
Bile acids play an important role in digestion and absorption of dietary 
fats and in the regulation of cholesterol homoeostasis. They are 
synthesized from cholesterol in the liver and secreted with bile into the 
intestine where they help in dietary fat digestion. They also play an 
important role as signaling molecules, capable of interacting with target 
nuclear receptors regulating their own transcription. 
The importance of bile acid enterohepatic circulation (recycling system) 
is related to the maintenance of bile acid and cholesterol balance. In the 
bile acids enterohepatic circulation, three key steps are present, mediated by: 
 a receptor system, that binds bile salts on one surface and translocates 
them into the cell; 
 a cellular bile salt binding protein, that transports bile acids across the cell; 
 an exit system, which moves bile salts out of the other side of the cell.
Much has been learned about the mechanism by which bile acids enter 
and exit liver and intestinal cells, but very little is known about how bile 
acids are shuttled in the cytosol, although the BABPs were proposed to 
act as the putative bile acid carriers in this compartment. 
The study presented here is aimed at the NMR structural 
characterization of the intracellular transporters present both in liver and 
ileum of chicken. In this regard, I have addressed the study of the 
interactions between: i) liver-BABP and a potential hepatospecific 
contrast agent, Gd-DTPA-conjugated to 5-cholanoic acid (Gd-I); ii) 
ileal-BABP and its physiological ligands, namely glycochenodeoxycholic 
and glycocholic acids (GCDA and GCA respectively).
The study of the mechanism involved in the intracellular transport of 
the bile acid-derived contrast agent in the hepatocytes is crucial for the 
definition of the drugs pharmacokinetics. An efficient contrast agent 
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should provide in fact a high contrast at low dose and have a rapid 
excretion after administration. The solution structure of liver-BABP in 
complex with the synthetic Gd-I has been obtained and fully described in 
paper N°1 (Tomaselli et al. J. Med. Chem., 2008, 51, 6782–6792). The 
relevance of the presented results is related to the identification of the 
molecular determinants of the interactions in the described system. The 
obtained structural data represent a necessary step to guide the rational 
design of hepatocyte-selective gadolinium chelates for liver targeting. 
 In the second part of my thesis I have investigated the binding 
features of  ileal-BABP with bile acid, employing both calorimetric and 
NMR approaches. The analysis described in paper N° 2 (Guariento et al.
Biochem. J., 2010, 425, 413–424) derived from ITC measurements in 
combination with NMR titration experiments indicated the absence of 
cooperative binding, at variance with the homologous human protein. The 
most relevant result of the paper is related to the identification of a 
system, the chicken ileal protein bound to bile salts, containing a protein 
scaffold which is able to establish a long-range communication network 
in spite of lack of cooperativity.  These findings set the basis for paper N° 
3, ready for submission, (Zanzoni et al .) which addresses the molecular 
determinants for a “gain-of-function” on going from non-mammalian to 
mammalian species. A high variety of NMR experiments has been 
combined to derive the structure of the ternary complex. The most 
relevant result of the paper is the identification, on the basis of extensive 
structural and bioinformatics analysis, of the key interaction capable of 
affecting the binding mechanism, introducing a gain of cooperativity. 
Thus it is likely that a well-tuned energetic coupling, necessary in a 
cooperativity interaction, has evolved due to an adaptation process for 
efficient  bile salt homeostasis. 
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